US5994041A
(en)
*
|
1985-04-06 |
1999-11-30 |
Eastman Kodak Company |
Process for buffering concentrated aqueous slurries
|
US5552154A
(en)
*
|
1989-11-06 |
1996-09-03 |
The Stehlin Foundation For Cancer Research |
Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof
|
US5552160A
(en)
*
|
1991-01-25 |
1996-09-03 |
Nanosystems L.L.C. |
Surface modified NSAID nanoparticles
|
AU642066B2
(en)
*
|
1991-01-25 |
1993-10-07 |
Nanosystems L.L.C. |
X-ray contrast compositions useful in medical imaging
|
US5399363A
(en)
*
|
1991-01-25 |
1995-03-21 |
Eastman Kodak Company |
Surface modified anticancer nanoparticles
|
SE9101090D0
(sv)
*
|
1991-04-11 |
1991-04-11 |
Astra Ab |
Process for conditioning of water-soluble substances
|
US5766635A
(en)
*
|
1991-06-28 |
1998-06-16 |
Rhone-Poulenc Rorer S.A. |
Process for preparing nanoparticles
|
US5811447A
(en)
|
1993-01-28 |
1998-09-22 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6515009B1
(en)
|
1991-09-27 |
2003-02-04 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5407659A
(en)
*
|
1991-10-22 |
1995-04-18 |
Mallinckrodt Medical, Inc. |
Treated calcium/oxyanion-containing particles for medical diagnostic imaging
|
US5342609A
(en)
*
|
1991-10-22 |
1994-08-30 |
Mallinckrodt Medical, Inc. |
Microfluidization of calcium/oxyanion-containing particles
|
US5344640A
(en)
*
|
1991-10-22 |
1994-09-06 |
Mallinckrodt Medical, Inc. |
Preparation of apatite particles for medical diagnostic imaging
|
US5916540A
(en)
*
|
1994-10-24 |
1999-06-29 |
Glaxo Group Limited |
Aerosol formulations containing P134A and/or P227 and particulate medicament
|
ATE260641T1
(de)
*
|
1991-12-18 |
2004-03-15 |
Minnesota Mining & Mfg |
Aerosolzusammensetzungen für arzneimittelsuspensionen
|
US7101534B1
(en)
|
1991-12-18 |
2006-09-05 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US7105152B1
(en)
|
1991-12-18 |
2006-09-12 |
3M Innovative Properties Company |
Suspension aerosol formulations
|
US6080751A
(en)
*
|
1992-01-14 |
2000-06-27 |
The Stehlin Foundation For Cancer Research |
Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof
|
ATE150297T1
(de)
*
|
1992-06-10 |
1997-04-15 |
Nanosystems Llc |
Oberflaechenmodifizierte nsaid nanopartikeln
|
US5552156A
(en)
*
|
1992-10-23 |
1996-09-03 |
Ohio State University |
Liposomal and micellular stabilization of camptothecin drugs
|
AU660852B2
(en)
*
|
1992-11-25 |
1995-07-06 |
Elan Pharma International Limited |
Method of grinding pharmaceutical substances
|
US5346702A
(en)
*
|
1992-12-04 |
1994-09-13 |
Sterling Winthrop Inc. |
Use of non-ionic cloud point modifiers to minimize nanoparticle aggregation during sterilization
|
US5298262A
(en)
*
|
1992-12-04 |
1994-03-29 |
Sterling Winthrop Inc. |
Use of ionic cloud point modifiers to prevent particle aggregation during sterilization
|
US5302401A
(en)
*
|
1992-12-09 |
1994-04-12 |
Sterling Winthrop Inc. |
Method to reduce particle size growth during lyophilization
|
US5340564A
(en)
*
|
1992-12-10 |
1994-08-23 |
Sterling Winthrop Inc. |
Formulations comprising olin 10-G to prevent particle aggregation and increase stability
|
US5336507A
(en)
*
|
1992-12-11 |
1994-08-09 |
Sterling Winthrop Inc. |
Use of charged phospholipids to reduce nanoparticle aggregation
|
US5429824A
(en)
*
|
1992-12-15 |
1995-07-04 |
Eastman Kodak Company |
Use of tyloxapole as a nanoparticle stabilizer and dispersant
|
US5256328A
(en)
*
|
1992-12-16 |
1993-10-26 |
Eastman Kodak Company |
Liquid toilet bowl cleaner and sanitizer containing halogen donating nanoparticles
|
US5364550A
(en)
*
|
1992-12-16 |
1994-11-15 |
Eastman Kodak Company |
Liquid detergent composition
|
US5352459A
(en)
*
|
1992-12-16 |
1994-10-04 |
Sterling Winthrop Inc. |
Use of purified surface modifiers to prevent particle aggregation during sterilization
|
US5322679A
(en)
*
|
1992-12-16 |
1994-06-21 |
Sterling Winthrop Inc. |
Iodinated aroyloxy esters
|
US5326552A
(en)
*
|
1992-12-17 |
1994-07-05 |
Sterling Winthrop Inc. |
Formulations for nanoparticulate x-ray blood pool contrast agents using high molecular weight nonionic surfactants
|
US5354564A
(en)
*
|
1992-12-18 |
1994-10-11 |
Eastman Kodak Company |
Personal care compositions
|
US6491938B2
(en)
|
1993-05-13 |
2002-12-10 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US6663881B2
(en)
|
1993-01-28 |
2003-12-16 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5981568A
(en)
*
|
1993-01-28 |
1999-11-09 |
Neorx Corporation |
Therapeutic inhibitor of vascular smooth muscle cells
|
US5916596A
(en)
|
1993-02-22 |
1999-06-29 |
Vivorx Pharmaceuticals, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6537579B1
(en)
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
FR2702160B1
(fr)
*
|
1993-03-02 |
1995-06-02 |
Biovecteurs As |
Vecteurs particulaires synthétiques et procédé de préparation.
|
US5830436A
(en)
*
|
1993-03-30 |
1998-11-03 |
Duke University |
Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
|
US5840277A
(en)
*
|
1993-03-30 |
1998-11-24 |
Charlotte Hospital Authority |
Treatment of chronic pulmonary inflammation
|
US5849263A
(en)
*
|
1993-03-30 |
1998-12-15 |
Charlotte-Mecklenburg Hospital Authority |
Pharmaceutical compositions containing alkylaryl polyether alcohol polymer
|
CH686761A5
(de)
|
1993-05-27 |
1996-06-28 |
Sandoz Ag |
Galenische Formulierungen.
|
US5543158A
(en)
*
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
US5635206A
(en)
*
|
1994-01-20 |
1997-06-03 |
Hoffmann-La Roche Inc. |
Process for liposomes or proliposomes
|
EP0678771B1
(en)
*
|
1994-04-18 |
2001-11-21 |
Eastman Kodak Company |
Stable aqueous solid particle dispersions
|
US5468598A
(en)
*
|
1994-04-18 |
1995-11-21 |
Eastman Kodak Company |
Solid particle dispersions for imaging systems
|
US5478705A
(en)
*
|
1994-05-25 |
1995-12-26 |
Eastman Kodak Company |
Milling a compound useful in imaging elements using polymeric milling media
|
TW384224B
(en)
*
|
1994-05-25 |
2000-03-11 |
Nano Sys Llc |
Method of preparing submicron particles of a therapeutic or diagnostic agent
|
US5500331A
(en)
*
|
1994-05-25 |
1996-03-19 |
Eastman Kodak Company |
Comminution with small particle milling media
|
US5513803A
(en)
*
|
1994-05-25 |
1996-05-07 |
Eastman Kodak Company |
Continuous media recirculation milling process
|
US5587143A
(en)
*
|
1994-06-28 |
1996-12-24 |
Nanosystems L.L.C. |
Butylene oxide-ethylene oxide block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
US6007845A
(en)
*
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
US5626862A
(en)
|
1994-08-02 |
1997-05-06 |
Massachusetts Institute Of Technology |
Controlled local delivery of chemotherapeutic agents for treating solid tumors
|
US20110196039A9
(en)
*
|
1994-10-05 |
2011-08-11 |
Kaesemeyer Wayne H |
Controlled release arginine formulations
|
DE4440337A1
(de)
*
|
1994-11-11 |
1996-05-15 |
Dds Drug Delivery Services Ges |
Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
|
US5955108A
(en)
*
|
1994-12-16 |
1999-09-21 |
Quadrant Healthcare (Uk) Limited |
Cross-linked microparticles and their use as therapeutic vehicles
|
US6524557B1
(en)
*
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US5609998A
(en)
*
|
1994-12-29 |
1997-03-11 |
Eastman Kodak Company |
Process for dispersing concentrated aqueous slurries
|
US5466440A
(en)
*
|
1994-12-30 |
1995-11-14 |
Eastman Kodak Company |
Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
|
US5628981A
(en)
*
|
1994-12-30 |
1997-05-13 |
Nano Systems L.L.C. |
Formulations of oral gastrointestinal diagnostic x-ray contrast agents and oral gastrointestinal therapeutic agents
|
US20020048596A1
(en)
*
|
1994-12-30 |
2002-04-25 |
Gregor Cevc |
Preparation for the transport of an active substance across barriers
|
US5585108A
(en)
*
|
1994-12-30 |
1996-12-17 |
Nanosystems L.L.C. |
Formulations of oral gastrointestinal therapeutic agents in combination with pharmaceutically acceptable clays
|
US5665331A
(en)
*
|
1995-01-10 |
1997-09-09 |
Nanosystems L.L.C. |
Co-microprecipitation of nanoparticulate pharmaceutical agents with crystal growth modifiers
|
US5716642A
(en)
*
|
1995-01-10 |
1998-02-10 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents using surface active material derived from similar pharmaceutical agents
|
US5560932A
(en)
*
|
1995-01-10 |
1996-10-01 |
Nano Systems L.L.C. |
Microprecipitation of nanoparticulate pharmaceutical agents
|
US5662883A
(en)
*
|
1995-01-10 |
1997-09-02 |
Nanosystems L.L.C. |
Microprecipitation of micro-nanoparticulate pharmaceutical agents
|
US5569448A
(en)
*
|
1995-01-24 |
1996-10-29 |
Nano Systems L.L.C. |
Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
|
US5520904A
(en)
*
|
1995-01-27 |
1996-05-28 |
Mallinckrodt Medical, Inc. |
Calcium/oxyanion-containing particles with a polymerical alkoxy coating for use in medical diagnostic imaging
|
AU4862796A
(en)
*
|
1995-02-06 |
1996-08-27 |
Nanosystems L.L.C. |
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
|
US5571536A
(en)
*
|
1995-02-06 |
1996-11-05 |
Nano Systems L.L.C. |
Formulations of compounds as nanoparticulate dispersions in digestible oils or fatty acids
|
US5665330A
(en)
*
|
1995-02-08 |
1997-09-09 |
Nano Systems Llc |
Dual purposed diagnostic/therapeutic agent having a tri-iodinated benzoyl group linked to a coumarin
|
US5503723A
(en)
*
|
1995-02-08 |
1996-04-02 |
Eastman Kodak Company |
Isolation of ultra small particles
|
US5622938A
(en)
*
|
1995-02-09 |
1997-04-22 |
Nano Systems L.L.C. |
Sugar base surfactant for nanocrystals
|
US5518738A
(en)
*
|
1995-02-09 |
1996-05-21 |
Nanosystem L.L.C. |
Nanoparticulate nsaid compositions
|
US5591456A
(en)
*
|
1995-02-10 |
1997-01-07 |
Nanosystems L.L.C. |
Milled naproxen with hydroxypropyl cellulose as a dispersion stabilizer
|
US5573783A
(en)
*
|
1995-02-13 |
1996-11-12 |
Nano Systems L.L.C. |
Redispersible nanoparticulate film matrices with protective overcoats
|
US5543133A
(en)
*
|
1995-02-14 |
1996-08-06 |
Nanosystems L.L.C. |
Process of preparing x-ray contrast compositions containing nanoparticles
|
US5510118A
(en)
*
|
1995-02-14 |
1996-04-23 |
Nanosystems Llc |
Process for preparing therapeutic compositions containing nanoparticles
|
WO1996025181A1
(en)
*
|
1995-02-14 |
1996-08-22 |
Nanosystems L.L.C. |
Process of preparing lymphography contrast agents
|
US5580579A
(en)
*
|
1995-02-15 |
1996-12-03 |
Nano Systems L.L.C. |
Site-specific adhesion within the GI tract using nanoparticles stabilized by high molecular weight, linear poly (ethylene oxide) polymers
|
ATE274341T1
(de)
*
|
1995-02-24 |
2004-09-15 |
Elan Pharma Int Ltd |
Nanopartikel-dispersionen enthaltende aerosole
|
US5565188A
(en)
*
|
1995-02-24 |
1996-10-15 |
Nanosystems L.L.C. |
Polyalkylene block copolymers as surface modifiers for nanoparticles
|
US5747001A
(en)
*
|
1995-02-24 |
1998-05-05 |
Nanosystems, L.L.C. |
Aerosols containing beclomethazone nanoparticle dispersions
|
US5736156A
(en)
*
|
1995-03-22 |
1998-04-07 |
The Ohio State University |
Liposomal anf micellular stabilization of camptothecin drugs
|
US5605696A
(en)
*
|
1995-03-30 |
1997-02-25 |
Advanced Cardiovascular Systems, Inc. |
Drug loaded polymeric material and method of manufacture
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
IL118088A0
(en)
*
|
1995-06-07 |
1996-08-04 |
Anzon Inc |
Colloidal particles of solid flame retardant and smoke suppressant compounds and methods for making them
|
ATE217792T1
(de)
*
|
1995-07-05 |
2002-06-15 |
Europ Economic Community |
Biokompatibele und biodegradierbare nanokapseln zur absorption und verabreichung von proteinischen arzneimitteln
|
FR2736550B1
(fr)
|
1995-07-14 |
1998-07-24 |
Sandoz Sa |
Composition pharmaceutique sous la forme d'une dispersion solide comprenant un macrolide et un vehicule
|
US6592877B1
(en)
*
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
US6290969B1
(en)
*
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
US6391338B1
(en)
*
|
1995-09-07 |
2002-05-21 |
Biovail Technologies Ltd. |
System for rendering substantially non-dissoluble bio-affecting agents bio-available
|
US5834025A
(en)
|
1995-09-29 |
1998-11-10 |
Nanosystems L.L.C. |
Reduction of intravenously administered nanoparticulate-formulation-induced adverse physiological reactions
|
DE69637441T2
(de)
|
1995-10-17 |
2009-03-05 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
US5679138A
(en)
*
|
1995-11-30 |
1997-10-21 |
Eastman Kodak Company |
Ink jet inks containing nanoparticles of organic pigments
|
US5662279A
(en)
*
|
1995-12-05 |
1997-09-02 |
Eastman Kodak Company |
Process for milling and media separation
|
US20050267302A1
(en)
*
|
1995-12-11 |
2005-12-01 |
G.D. Searle & Co. |
Eplerenone crystalline form exhibiting enhanced dissolution rate
|
US5968543A
(en)
*
|
1996-01-05 |
1999-10-19 |
Advanced Polymer Systems, Inc. |
Polymers with controlled physical state and bioerodibility
|
US5686133A
(en)
*
|
1996-01-31 |
1997-11-11 |
Port Systems, L.L.C. |
Water soluble pharmaceutical coating and method for producing coated pharmaceuticals
|
US5611344A
(en)
*
|
1996-03-05 |
1997-03-18 |
Acusphere, Inc. |
Microencapsulated fluorinated gases for use as imaging agents
|
IL126073A
(en)
*
|
1996-03-05 |
2002-02-10 |
Acusphere Inc |
Microencapsulated fluorinated gases for use as imaging agents
|
AU702955B2
(en)
*
|
1996-05-17 |
1999-03-11 |
Quadrant Healthcare (Uk) Limited |
Microparticles and their use in wound therapy
|
BR9710682A
(pt)
|
1996-05-24 |
1999-08-17 |
Angiotech Pharm Inc |
Composi-{es e m-todos para tratar ou prevenir doen-as das vias do organismo
|
US6254854B1
(en)
*
|
1996-05-24 |
2001-07-03 |
The Penn Research Foundation |
Porous particles for deep lung delivery
|
US6503480B1
(en)
|
1997-05-23 |
2003-01-07 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
US20020052310A1
(en)
*
|
1997-09-15 |
2002-05-02 |
Massachusetts Institute Of Technology The Penn State Research Foundation |
Particles for inhalation having sustained release properties
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
USRE37053E1
(en)
|
1996-05-24 |
2001-02-13 |
Massachusetts Institute Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
US6652837B1
(en)
*
|
1996-05-24 |
2003-11-25 |
Massachusetts Institute Of Technology |
Preparation of novel particles for inhalation
|
US5726154A
(en)
*
|
1996-06-28 |
1998-03-10 |
University Of Utah Research Foundation |
Stabilization and oral delivery of calcitonin
|
US5837221A
(en)
*
|
1996-07-29 |
1998-11-17 |
Acusphere, Inc. |
Polymer-lipid microencapsulated gases for use as imaging agents
|
US5935890A
(en)
|
1996-08-01 |
1999-08-10 |
Glcc Technologies, Inc. |
Stable dispersions of metal passivation agents and methods for making them
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US7255877B2
(en)
*
|
1996-08-22 |
2007-08-14 |
Jagotec Ag |
Fenofibrate microparticles
|
US7060253B1
(en)
*
|
1996-09-20 |
2006-06-13 |
Mundschenk David D |
Topical formulations and delivery systems
|
GB9622173D0
(en)
*
|
1996-10-24 |
1996-12-18 |
Glaxo Group Ltd |
Particulate Products
|
US6515016B2
(en)
|
1996-12-02 |
2003-02-04 |
Angiotech Pharmaceuticals, Inc. |
Composition and methods of paclitaxel for treating psoriasis
|
FR2758459B1
(fr)
*
|
1997-01-17 |
1999-05-07 |
Pharma Pass |
Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
|
US5993856A
(en)
*
|
1997-01-24 |
1999-11-30 |
Femmepharma |
Pharmaceutical preparations and methods for their administration
|
US6416778B1
(en)
*
|
1997-01-24 |
2002-07-09 |
Femmepharma |
Pharmaceutical preparations and methods for their regional administration
|
US6045829A
(en)
*
|
1997-02-13 |
2000-04-04 |
Elan Pharma International Limited |
Nanocrystalline formulations of human immunodeficiency virus (HIV) protease inhibitors using cellulosic surface stabilizers
|
WO1998035666A1
(en)
*
|
1997-02-13 |
1998-08-20 |
Nanosystems Llc |
Formulations of nanoparticle naproxen tablets
|
CO4920215A1
(es)
*
|
1997-02-14 |
2000-05-29 |
Novartis Ag |
Tabletas de oxacarbazepina recubiertas de una pelicula y metodo para la produccion de estas formulaciones
|
US20050004049A1
(en)
*
|
1997-03-11 |
2005-01-06 |
Elan Pharma International Limited |
Novel griseofulvin compositions
|
US5989591A
(en)
*
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
US6193954B1
(en)
*
|
1997-03-21 |
2001-02-27 |
Abbott Laboratories |
Formulations for pulmonary delivery of dopamine agonists
|
WO1998047492A1
(en)
*
|
1997-04-18 |
1998-10-29 |
Vertex Pharmaceuticals Incorporated |
Nanosized aspartyl protease inhibitors
|
CA2288789C
(en)
|
1997-05-08 |
2009-07-21 |
Merck Sharp & Dohme Limited |
Substituted 1,2,4-triazolo[3,4-a]phthalazine derivatives as gaba alpha 5 ligands
|
US7087713B2
(en)
*
|
2000-02-25 |
2006-08-08 |
Corixa Corporation |
Compounds and methods for diagnosis and immunotherapy of tuberculosis
|
IT1292142B1
(it)
*
|
1997-06-12 |
1999-01-25 |
Maria Rosa Gasco |
Composizione farmaceutica in forma di microparticelle lipidiche solide atte alla somministrazione parenterale
|
WO1998057648A1
(en)
*
|
1997-06-16 |
1998-12-23 |
Vertex Pharmaceuticals Incorporated |
Methods of increasing the bioavailability of stable crystal polymorphs of a compound
|
SG165156A1
(en)
|
1997-06-27 |
2010-10-28 |
Abraxis Bioscience Llc |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
CN100462066C
(zh)
*
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
药剂的新制剂及其制备和应用方法
|
US7052678B2
(en)
|
1997-09-15 |
2006-05-30 |
Massachusetts Institute Of Technology |
Particles for inhalation having sustained release properties
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6946117B1
(en)
*
|
1997-09-29 |
2005-09-20 |
Nektar Therapeutics |
Stabilized preparations for use in nebulizers
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6919070B1
(en)
*
|
1997-10-17 |
2005-07-19 |
Zakrytoe Aktsionernoe Obschestvo “OSTIM” |
Stomatic composition
|
UA72189C2
(uk)
*
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
GB9726543D0
(en)
*
|
1997-12-16 |
1998-02-11 |
Smithkline Beecham Plc |
Novel compositions
|
US6086376A
(en)
*
|
1998-01-30 |
2000-07-11 |
Rtp Pharma Inc. |
Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant
|
YU46500A
(sh)
|
1998-02-25 |
2002-11-15 |
Merck Charp & Dohme Limited |
Substituisani 1,2,4-triazolo /3,4-a/piridazin
|
ZA991922B
(en)
*
|
1998-03-11 |
1999-09-13 |
Smithkline Beecham Corp |
Novel compositions of eprosartan.
|
US20020147143A1
(en)
|
1998-03-18 |
2002-10-10 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of lung cancer
|
CN1303278B
(zh)
*
|
1998-03-30 |
2010-06-23 |
斯凯伊药品加拿大公司 |
制备水不溶性物质微粒的组合物和方法
|
US6337092B1
(en)
|
1998-03-30 |
2002-01-08 |
Rtp Pharma Inc. |
Composition and method of preparing microparticles of water-insoluble substances
|
US6979456B1
(en)
|
1998-04-01 |
2005-12-27 |
Jagotec Ag |
Anticancer compositions
|
WO1999061001A1
(en)
|
1998-05-29 |
1999-12-02 |
Rtp Pharma Inc. |
Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
|
US6153225A
(en)
*
|
1998-08-13 |
2000-11-28 |
Elan Pharma International Limited |
Injectable formulations of nanoparticulate naproxen
|
US6956021B1
(en)
|
1998-08-25 |
2005-10-18 |
Advanced Inhalation Research, Inc. |
Stable spray-dried protein formulations
|
US6165506A
(en)
*
|
1998-09-04 |
2000-12-26 |
Elan Pharma International Ltd. |
Solid dose form of nanoparticulate naproxen
|
US20030235557A1
(en)
|
1998-09-30 |
2003-12-25 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
EP1117384A1
(en)
*
|
1998-10-01 |
2001-07-25 |
Elan Pharma International Limited |
Controlled release nanoparticulate compositions
|
US20070160675A1
(en)
*
|
1998-11-02 |
2007-07-12 |
Elan Corporation, Plc |
Nanoparticulate and controlled release compositions comprising a cephalosporin
|
PL205109B1
(pl)
*
|
1998-11-02 |
2010-03-31 |
Elan Pharma Int Ltd |
Wielocząstkowa kompozycja metylofenidatu o modyfikowanym uwalnianiu i jej zastosowanie
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
AU768994B2
(en)
*
|
1998-11-12 |
2004-01-15 |
Smithkline Beecham Plc |
Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
|
US7521068B2
(en)
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US6969529B2
(en)
*
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
GB9824897D0
(en)
|
1998-11-12 |
1999-01-06 |
Merck Sharp & Dohme |
Therapeutic compounds
|
US6375986B1
(en)
|
2000-09-21 |
2002-04-23 |
Elan Pharma International Ltd. |
Solid dose nanoparticulate compositions comprising a synergistic combination of a polymeric surface stabilizer and dioctyl sodium sulfosuccinate
|
AU767154B2
(en)
|
1998-11-20 |
2003-10-30 |
Skyepharma Canada Inc. |
Dispersible phospholipid stabilized microparticles
|
ES2350454T3
(es)
|
1998-11-27 |
2011-01-24 |
Ucb Pharma S.A. |
Composiciones y métodos para incrementar la mineralización de la sustancia ósea.
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
DE19856432A1
(de)
*
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
ES2173679T3
(es)
|
1999-01-27 |
2002-10-16 |
Idea Ag |
Inmunizacion/transporte transnasal con vehiculos altamente adaptables.
|
SI1031346T1
(en)
|
1999-01-27 |
2002-08-31 |
Idea Ag |
Noninvasive vaccination through the skin
|
US7374779B2
(en)
*
|
1999-02-26 |
2008-05-20 |
Lipocine, Inc. |
Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
|
US6267985B1
(en)
*
|
1999-06-30 |
2001-07-31 |
Lipocine Inc. |
Clear oil-containing pharmaceutical compositions
|
US6761903B2
(en)
|
1999-06-30 |
2004-07-13 |
Lipocine, Inc. |
Clear oil-containing pharmaceutical compositions containing a therapeutic agent
|
US6294192B1
(en)
|
1999-02-26 |
2001-09-25 |
Lipocine, Inc. |
Triglyceride-free compositions and methods for improved delivery of hydrophobic therapeutic agents
|
US6270806B1
(en)
|
1999-03-03 |
2001-08-07 |
Elan Pharma International Limited |
Use of peg-derivatized lipids as surface stabilizers for nanoparticulate compositions
|
US6267989B1
(en)
*
|
1999-03-08 |
2001-07-31 |
Klan Pharma International Ltd. |
Methods for preventing crystal growth and particle aggregation in nanoparticulate compositions
|
EG23951A
(en)
|
1999-03-25 |
2008-01-29 |
Otsuka Pharma Co Ltd |
Cilostazol preparation
|
US6383471B1
(en)
|
1999-04-06 |
2002-05-07 |
Lipocine, Inc. |
Compositions and methods for improved delivery of ionizable hydrophobic therapeutic agents
|
US8143386B2
(en)
*
|
1999-04-07 |
2012-03-27 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis antigens and their uses
|
AU4225700A
(en)
*
|
1999-04-12 |
2000-11-14 |
Dow Agrosciences Llc |
Aqueous dispersions of agricultural chemicals
|
US6491239B2
(en)
|
1999-05-06 |
2002-12-10 |
Eastman Kodak Company |
Process for milling compounds
|
US6309749B1
(en)
|
1999-05-06 |
2001-10-30 |
Eastman Kodak Company |
Ceramic milling media containing tetragonal zirconia
|
US6444223B1
(en)
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
DE60012520T3
(de)
|
1999-06-01 |
2009-06-25 |
Elan Pharma International Ltd. |
Kleinmühle und verfahren dafür
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
ES2526707T3
(es)
*
|
1999-06-29 |
2015-01-14 |
Mannkind Corporation |
Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
|
US9006175B2
(en)
*
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
US6982281B1
(en)
*
|
2000-11-17 |
2006-01-03 |
Lipocine Inc |
Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
|
US6309663B1
(en)
|
1999-08-17 |
2001-10-30 |
Lipocine Inc. |
Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
|
US6458383B2
(en)
|
1999-08-17 |
2002-10-01 |
Lipocine, Inc. |
Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
|
AU5409699A
(en)
*
|
1999-07-05 |
2001-01-22 |
Idea Ag |
A method for the improvement of transport across adaptable semi-permeable barriers
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
FR2795961B1
(fr)
*
|
1999-07-09 |
2004-05-28 |
Ethypharm Lab Prod Ethiques |
Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
|
US7863331B2
(en)
*
|
1999-07-09 |
2011-01-04 |
Ethypharm |
Pharmaceutical composition containing fenofibrate and method for the preparation thereof
|
MXPA02001505A
(es)
|
1999-08-12 |
2002-07-02 |
Lilly Co Eli |
Tratamiento oral de animales de compania con spinosyns actoparasiticida.
|
US6927210B1
(en)
|
1999-08-12 |
2005-08-09 |
Eli Lilly And Company |
Ectoparasiticidal aqueous suspension formulations of spinosyns
|
US6933318B1
(en)
|
1999-08-12 |
2005-08-23 |
Eli Lilly And Company |
Topical organic ectoparasiticidal formulations
|
US6749835B1
(en)
|
1999-08-25 |
2004-06-15 |
Advanced Inhalation Research, Inc. |
Formulation for spray-drying large porous particles
|
US7678364B2
(en)
|
1999-08-25 |
2010-03-16 |
Alkermes, Inc. |
Particles for inhalation having sustained release properties
|
US20010036481A1
(en)
*
|
1999-08-25 |
2001-11-01 |
Advanced Inhalation Research, Inc. |
Modulation of release from dry powder formulations
|
AU763041B2
(en)
*
|
1999-08-25 |
2003-07-10 |
Alkermes, Inc. |
Modulation of release from dry powder formulations
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
CA2386841A1
(en)
*
|
1999-10-07 |
2001-04-12 |
Corixa Corporation |
Fusion proteins of mycobacterium tuberculosis
|
ATE526950T1
(de)
|
1999-10-29 |
2011-10-15 |
Euro Celtique Sa |
Hydrocodon-formulierungen mit gesteuerter freisetzung
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
US20030096798A1
(en)
*
|
1999-11-09 |
2003-05-22 |
Williams Gordon H. |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
US20030203884A1
(en)
*
|
1999-11-09 |
2003-10-30 |
Pharmacia Corporation |
Methods for the treatment or prophylaxis of aldosterone-mediated pathogenic effects in a subject using an epoxy-steroidal aldosterone antagonist
|
AUPQ441699A0
(en)
|
1999-12-02 |
2000-01-06 |
Eli Lilly And Company |
Pour-on formulations
|
US20030083493A1
(en)
*
|
1999-12-08 |
2003-05-01 |
Barton Kathleen P. |
Eplerenone drug substance having high phase purity
|
IL144757A0
(en)
*
|
1999-12-08 |
2002-06-30 |
Pharmacia Corp |
Eplerenone crystalline form
|
UA74539C2
(en)
|
1999-12-08 |
2006-01-16 |
Pharmacia Corp |
Crystalline polymorphous forms of celecoxib (variants), a method for the preparation thereof (variants), a pharmaceutical composition (variants)
|
US6251136B1
(en)
|
1999-12-08 |
2001-06-26 |
Advanced Cardiovascular Systems, Inc. |
Method of layering a three-coated stent using pharmacological and polymeric agents
|
CA2362815A1
(en)
*
|
1999-12-08 |
2001-06-14 |
Pharmacia Corporation |
Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
|
US6702849B1
(en)
|
1999-12-13 |
2004-03-09 |
Advanced Cardiovascular Systems, Inc. |
Method of processing open-celled microcellular polymeric foams with controlled porosity for use as vascular grafts and stent covers
|
WO2001045677A1
(en)
|
1999-12-20 |
2001-06-28 |
Kerkhof Nicholas J |
Process for producing nanometer particles by fluid bed spray-drying
|
US8771740B2
(en)
*
|
1999-12-20 |
2014-07-08 |
Nicholas J. Kerkhof |
Process for producing nanoparticles by spray drying
|
GB9930562D0
(en)
*
|
1999-12-23 |
2000-02-16 |
Boc Group Plc |
Partial oxidation of hydrogen sulphide
|
CN1402629A
(zh)
|
1999-12-23 |
2003-03-12 |
辉瑞产品公司 |
提供提高的药物浓度的药物组合物
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
WO2001058238A2
(en)
|
2000-01-31 |
2001-08-16 |
Collaborative Technologies, Inc. |
Method and system for producing customized cosmetic and pharmaceutical formulations on demand
|
JP5502253B2
(ja)
|
2000-02-23 |
2014-05-28 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
新規化合物
|
US6632671B2
(en)
*
|
2000-02-28 |
2003-10-14 |
Genesegues, Inc. |
Nanoparticle encapsulation system and method
|
US20040002068A1
(en)
|
2000-03-01 |
2004-01-01 |
Corixa Corporation |
Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
|
AUPQ634300A0
(en)
*
|
2000-03-20 |
2000-04-15 |
Eli Lilly And Company |
Synergistic formulations
|
US7153525B1
(en)
*
|
2000-03-22 |
2006-12-26 |
The University Of Kentucky Research Foundation |
Microemulsions as precursors to solid nanoparticles
|
US6992081B2
(en)
|
2000-03-23 |
2006-01-31 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
EP1265849B1
(en)
|
2000-03-23 |
2006-10-25 |
Elan Pharmaceuticals, Inc. |
Compounds and methods to treat alzheimer's disease
|
GB0009773D0
(en)
*
|
2000-04-19 |
2000-06-07 |
Univ Cardiff |
Particulate composition
|
EP1276465B1
(en)
|
2000-04-20 |
2014-03-12 |
Jagotec AG |
Improved water-insoluble drug particle process
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
TWI290473B
(en)
*
|
2000-05-10 |
2007-12-01 |
Alliance Pharma |
Phospholipid-based powders for drug delivery
|
ES2303527T3
(es)
|
2000-05-10 |
2008-08-16 |
Jagotec Ag |
Procedimiento de molienda.
|
US6316029B1
(en)
*
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
AR035642A1
(es)
*
|
2000-05-26 |
2004-06-23 |
Pharmacia Corp |
Uso de una composicion de celecoxib para el alivio rapido del dolor
|
DE60139963D1
(de)
|
2000-06-20 |
2009-10-29 |
Corixa Corp |
Fusionsproteine aus mycobakterium tuberculosis
|
RU2003101969A
(ru)
*
|
2000-06-27 |
2004-07-10 |
Дженелэбс Текнолоджиз, Инк. (Us) |
Новые соединения, обладающие антибактериальной, противогрибковой и противоопухолевой активностью
|
ATE396265T1
(de)
|
2000-06-28 |
2008-06-15 |
Corixa Corp |
Zusammensetzungen und verfahren für therapie und diagnose von lungenkrebs
|
EP1666452A2
(en)
|
2000-06-30 |
2006-06-07 |
Elan Pharmaceuticals, Inc. |
Compounds to treat Alzheimer's disease
|
US6846813B2
(en)
*
|
2000-06-30 |
2005-01-25 |
Pharmacia & Upjohn Company |
Compounds to treat alzheimer's disease
|
PE20020276A1
(es)
|
2000-06-30 |
2002-04-06 |
Elan Pharm Inc |
COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
|
EP1299349B1
(en)
*
|
2000-06-30 |
2005-08-24 |
Elan Pharmaceuticals, Inc. |
Compounds to treat alzheimer's disease
|
US20030096864A1
(en)
*
|
2000-06-30 |
2003-05-22 |
Fang Lawrence Y. |
Compounds to treat alzheimer's disease
|
IN192160B
(fi)
*
|
2000-07-17 |
2004-02-28 |
Ranbaxy Lab |
|
US6656505B2
(en)
*
|
2000-07-21 |
2003-12-02 |
Alpharma Uspd Inc. |
Method for forming an aqueous flocculated suspension
|
US6716829B2
(en)
|
2000-07-27 |
2004-04-06 |
Pharmacia Corporation |
Aldosterone antagonist and cyclooxygenase-2 inhibitor combination therapy to prevent or treat inflammation-related cardiovascular disorders
|
JP2004511435A
(ja)
*
|
2000-07-27 |
2004-04-15 |
ファルマシア・コーポレーション |
うっ血性心不全の処置のための、エポキシ−ステロイド型アルドステロン拮抗薬とβ−アドレナリン作動性拮抗薬の併用療法
|
WO2002017895A2
(en)
*
|
2000-08-28 |
2002-03-07 |
Pharmacia Corporation |
Use of an aldosterone receptor antagonist to improve cognitive function
|
CA2420597C
(en)
|
2000-08-31 |
2011-05-17 |
Rtp Pharma Inc. |
Milled particles
|
US8586094B2
(en)
|
2000-09-20 |
2013-11-19 |
Jagotec Ag |
Coated tablets
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US7198795B2
(en)
*
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
CA2427815C
(en)
|
2000-10-30 |
2007-07-10 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
US8551526B2
(en)
*
|
2000-11-03 |
2013-10-08 |
Board Of Regents, The University Of Texas System |
Preparation of drug particles using evaporation precipitation into aqueous solutions
|
US6756062B2
(en)
|
2000-11-03 |
2004-06-29 |
Board Of Regents University Of Texas System |
Preparation of drug particles using evaporation precipitation into aqueous solutions
|
US20030198679A1
(en)
*
|
2000-11-08 |
2003-10-23 |
Kundu Subhas C. |
Flocculated pharmaceutical suspensions and methods for actives
|
DE60136490D1
(de)
*
|
2000-11-09 |
2008-12-18 |
Neopharm Inc |
Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
|
GB0028583D0
(en)
*
|
2000-11-23 |
2001-01-10 |
Merck Sharp & Dohme |
Therapeutic compounds
|
EP2168571B1
(en)
|
2000-11-30 |
2018-08-22 |
Vectura Limited |
Particles for use in a Pharmaceutical Composition
|
ES2708961T3
(es)
|
2000-11-30 |
2019-04-12 |
Vectura Ltd |
Composiciones farmacéuticas para inhalación
|
JP2004518642A
(ja)
*
|
2000-12-06 |
2004-06-24 |
ファルマシア・コーポレーション |
ラボラトリースケールの微粉砕化プロセス
|
WO2002048142A1
(fr)
*
|
2000-12-11 |
2002-06-20 |
Takeda Chemical Industries, Ltd. |
Compositions medicamenteuses presentant une meilleure absorbabilite
|
DE10063092A1
(de)
*
|
2000-12-18 |
2002-06-20 |
Henkel Kgaa |
Nanoskalige Materialien in Hygiene-Produkten
|
DE10063090A1
(de)
*
|
2000-12-18 |
2002-06-20 |
Henkel Kgaa |
Nanoskaliges ZnO in Hygiene-Produkten
|
US6982251B2
(en)
*
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
MXPA03005496A
(es)
*
|
2000-12-22 |
2004-05-14 |
Baxter Int |
Metodo para preparar suspensiones de submicroparticulas.
|
US20040022862A1
(en)
*
|
2000-12-22 |
2004-02-05 |
Kipp James E. |
Method for preparing small particles
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
US20050048126A1
(en)
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20030072807A1
(en)
*
|
2000-12-22 |
2003-04-17 |
Wong Joseph Chung-Tak |
Solid particulate antifungal compositions for pharmaceutical use
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US6869617B2
(en)
*
|
2000-12-22 |
2005-03-22 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US9700866B2
(en)
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US20020198254A1
(en)
*
|
2000-12-27 |
2002-12-26 |
Velligan Mark D. |
Polyamide analogs
|
US20030125236A1
(en)
*
|
2000-12-29 |
2003-07-03 |
Advenced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
EP1345629A2
(en)
|
2000-12-29 |
2003-09-24 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having sustained release properties
|
US20020141946A1
(en)
*
|
2000-12-29 |
2002-10-03 |
Advanced Inhalation Research, Inc. |
Particles for inhalation having rapid release properties
|
FI20010115A0
(fi)
*
|
2001-01-18 |
2001-01-18 |
Orion Corp |
Menetelmä nanopartikkelien valmistamiseksi
|
US7071181B2
(en)
*
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
PL369033A1
(en)
*
|
2001-01-26 |
2005-04-18 |
Schering Corporation |
Combinations of sterol absorption inhibitor(s) with cardiovascular agent(s) for the treatment of vascular conditions
|
WO2002058733A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Schering Corporation |
Combinations of bile acid sequestrant(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
JP4777602B2
(ja)
*
|
2001-01-26 |
2011-09-21 |
シェーリング コーポレイション |
ペルオキシソーム増殖因子活性化レセプター(ppar)活性化剤およびステロール吸収阻害剤の組合せおよび血管症状の処置
|
US20020183305A1
(en)
*
|
2001-01-26 |
2002-12-05 |
Schering Corporation |
Combinations of nicotinic acid and derivatives thereof and sterol absorption inhibitor(s) and treatments for vascular indications
|
PL205343B1
(pl)
*
|
2001-01-26 |
2010-04-30 |
Schering Corp |
Zastosowanie inhibitora wchłaniania sterolu
|
DE60224163T2
(de)
*
|
2001-01-26 |
2008-12-04 |
Schering Corp. |
Kombinationen von ezetimibe und aspirin zur behandlung von kardiovaskulären erkrankungen
|
US20040022861A1
(en)
*
|
2001-01-30 |
2004-02-05 |
Williams Robert O. |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
AU2002243760A1
(en)
*
|
2001-01-30 |
2002-08-12 |
Board Of Regents University Of Texas System |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
US6497896B2
(en)
|
2001-02-12 |
2002-12-24 |
Supergen, Inc. |
Method for administering camptothecins via injection of a pharmaceutical composition comprising microdroplets containing a camptothecin
|
US6509027B2
(en)
|
2001-02-12 |
2003-01-21 |
Supergen, Inc. |
Injectable pharmaceutical composition comprising coated particles of camptothecin
|
US20020150615A1
(en)
*
|
2001-02-12 |
2002-10-17 |
Howard Sands |
Injectable pharmaceutical composition comprising microdroplets of a camptothecin
|
JP3386052B2
(ja)
*
|
2001-02-13 |
2003-03-10 |
トヨタ自動車株式会社 |
ポンプ装置
|
CN101230067B
(zh)
|
2001-02-14 |
2011-06-15 |
泰博特克药品有限公司 |
广谱的2-(取代-氨基)-苯并噻唑磺酰胺hiv蛋白酶抑制剂
|
JP2004523552A
(ja)
*
|
2001-02-22 |
2004-08-05 |
スカイファーマ・カナダ・インコーポレーテッド |
低減した摂食−絶食効果を伴うフィブラート−スタチンの組合わせ
|
KR100607742B1
(ko)
*
|
2001-04-03 |
2006-08-01 |
쉐링 코포레이션 |
안정한 액상 현탁제, 및 이를 함유하는, 생체 이용율이 증진된 항진균성 조성물
|
AU2002245979A1
(en)
*
|
2001-04-05 |
2002-10-21 |
Universite Laval |
Process for making protein delivery matrix and uses thereof
|
AU2002257774B2
(en)
|
2001-04-09 |
2007-08-30 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors
|
US20040126900A1
(en)
*
|
2001-04-13 |
2004-07-01 |
Barry Stephen E |
High affinity peptide- containing nanoparticles
|
US6667344B2
(en)
|
2001-04-17 |
2003-12-23 |
Dey, L.P. |
Bronchodilating compositions and methods
|
CA2445763A1
(en)
*
|
2001-05-01 |
2002-11-07 |
Angiotech Pharmaceuticals Inc. |
Compositions comprising an anti-microtubule agent and a polypeptide or a polysaccharide and the use thereof for the preparation of a medicament for the treatment of inflammatory conditions
|
US20030157161A1
(en)
*
|
2001-05-01 |
2003-08-21 |
Angiotech Pharmaceuticals, Inc. |
Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
|
ITMO20010086A1
(it)
*
|
2001-05-08 |
2002-11-08 |
Worgas Bruciatori Srl |
Metodo ed apparato per ridurre le emissioni di biossido di azoto (no2)in un apparecchio da riscaldamento senza canna fumaria
|
CA2446788A1
(en)
|
2001-05-09 |
2002-11-14 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of prostate cancer
|
EP1387842B1
(en)
|
2001-05-11 |
2009-04-22 |
Tibotec Pharmaceuticals Ltd. |
Broadspectrum 2-amino-benzoxazole sulfonamide hiv protease inhibitors
|
DE10125290B4
(de)
*
|
2001-05-15 |
2005-04-14 |
Siemens Ag |
Verfahren zum Aufbereiten von Nano-Dispersanten
|
KR20040002991A
(ko)
*
|
2001-05-23 |
2004-01-07 |
이 아이 듀폰 디 네모아 앤드 캄파니 |
고압 매체 및 초미세 입자의 제조 방법
|
PT1392287E
(pt)
*
|
2001-05-25 |
2007-02-28 |
Schering Corp |
Métodos para tratamento de doença de alzheimer e/ou regulação dos níveis de peptídeos β amilóide num sujeito
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
ES2309177T3
(es)
*
|
2001-06-05 |
2008-12-16 |
Elan Pharma International Limited |
Sistema y metodo para moler materiales.
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
US6730319B2
(en)
|
2001-06-06 |
2004-05-04 |
Hoffmann-La Roche Inc. |
Pharmaceutical compositions having depressed melting points
|
US20040173146A1
(en)
*
|
2001-06-07 |
2004-09-09 |
Figueroa Iddys D. |
Application of a bioactive agent to a delivery substrate
|
US20040173147A1
(en)
*
|
2001-06-07 |
2004-09-09 |
Figueroa Iddys D. |
Application of a bioactive agent to a delivery substrate
|
US6962715B2
(en)
*
|
2001-10-24 |
2005-11-08 |
Hewlett-Packard Development Company, L.P. |
Method and dosage form for dispensing a bioactive substance
|
EP1395251A2
(en)
|
2001-06-13 |
2004-03-10 |
Elan Pharmaceuticals, Inc. |
Aminediols as agents for the treatment of alzheimer's disease
|
GB0114532D0
(en)
*
|
2001-06-14 |
2001-08-08 |
Jagotec Ag |
Novel compositions
|
EP1269994A3
(en)
*
|
2001-06-22 |
2003-02-12 |
Pfizer Products Inc. |
Pharmaceutical compositions comprising drug and concentration-enhancing polymers
|
CA2450748A1
(en)
*
|
2001-06-22 |
2003-01-03 |
Pfizer Products Inc. |
Pharmaceutical compositions containing polymer and drug assemblies
|
EP1401401B1
(en)
*
|
2001-06-22 |
2005-03-30 |
Marie Lindner |
Method for high through put screening using a small scale mill or microfluidics
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
MXPA04000140A
(es)
*
|
2001-06-27 |
2004-06-03 |
Elan Pharm Inc |
Derivados de beta-hidroxiamina utiles en el tratamiento de enfermedad de alzheimer.
|
BR0211121A
(pt)
*
|
2001-07-10 |
2004-10-26 |
Elan Pharm Inc |
Composto, métodos para o tratamento ou prevenção de doenças e para fabricar um composto, intermediário, e, uso de um composto ou sal
|
WO2003006013A1
(en)
*
|
2001-07-10 |
2003-01-23 |
Elan Pharmaceuticals, Inc. |
Diaminediols for the treatment of alzheimer's disease
|
GB0208742D0
(en)
|
2002-04-17 |
2002-05-29 |
Bradford Particle Design Ltd |
Particulate materials
|
US20030220310A1
(en)
*
|
2001-07-27 |
2003-11-27 |
Schuh Joseph R. |
Epoxy-steroidal aldosterone antagonist and calcium channel blocker combination therapy for treatment of congestive heart failure
|
US20080305173A1
(en)
*
|
2001-07-31 |
2008-12-11 |
Beuford Arlie Bogue |
Amorphous drug beads
|
AU2002317409B2
(en)
*
|
2001-08-06 |
2007-06-21 |
Astrazeneca Ab |
Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (MCT)
|
GB0119480D0
(en)
*
|
2001-08-09 |
2001-10-03 |
Jagotec Ag |
Novel compositions
|
MY169670A
(en)
|
2003-09-03 |
2019-05-08 |
Tibotec Pharm Ltd |
Combinations of a pyrimidine containing nnrti with rt inhibitors
|
US20030049323A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Hitt James E. |
Process to precipitate drug particles
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
MXPA04002477A
(es)
*
|
2001-09-17 |
2004-05-31 |
Lilly Co Eli |
Formulaciones pesticidas.
|
ES2280582T3
(es)
*
|
2001-09-19 |
2007-09-16 |
Elan Pharma International Limited |
Formulaciones de insulina en nanoparticulas.
|
AU2002336609B2
(en)
*
|
2001-09-21 |
2006-08-24 |
Merck Sharp & Dohme Corp. |
Treatment of xanthoma with azetidinone derivatives as sterol absorption inhibitors
|
DE60229406D1
(de)
*
|
2001-09-21 |
2008-11-27 |
Schering Corp |
Verfahren zur behandlung oder verhinderung von vaskulärer entzündung mit sterol-absorbierungs- inhibitor(en)
|
US7056906B2
(en)
*
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
US20030119808A1
(en)
*
|
2001-09-21 |
2003-06-26 |
Schering Corporation |
Methods of treating or preventing cardiovascular conditions while preventing or minimizing muscular degeneration side effects
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
US6872725B2
(en)
*
|
2001-09-25 |
2005-03-29 |
Pharmacia Corporation |
Solid-state forms of N-(2-hydroxyacetyl)-5-(4-piperidyl)-4-(4-pyrimidinyl)-3-(4-chlorophenyl) pyrazole
|
JP2005504090A
(ja)
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
US20060003012A9
(en)
*
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
US7544681B2
(en)
*
|
2001-09-27 |
2009-06-09 |
Ramot At Tel Aviv University Ltd. |
Conjugated psychotropic drugs and uses thereof
|
US20050191359A1
(en)
*
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
US6878693B2
(en)
*
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
WO2003029169A2
(en)
|
2001-10-04 |
2003-04-10 |
Elan Pharmaceuticals, Inc. |
Hydroxypropylamines
|
DE60222160T2
(de)
*
|
2001-10-12 |
2008-06-12 |
Elan Pharma International Ltd., Athlone |
Zusammensetzungen mit einer kombination aus eigenschaften sofortiger freisetzung und kontrollierter freisetzung
|
WO2003032906A2
(en)
*
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
TWI330183B
(fi)
*
|
2001-10-22 |
2010-09-11 |
Eisai R&D Man Co Ltd |
|
WO2003039601A1
(en)
*
|
2001-11-07 |
2003-05-15 |
Imcor Pharmaceutical Company |
Methods for vascular imaging using nanoparticulate contrast agents
|
OA12846A
(en)
*
|
2001-11-08 |
2006-09-15 |
Elan Pharm Inc |
N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives.
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
EP1448177A1
(en)
*
|
2001-11-19 |
2004-08-25 |
Elan Pharmaceuticals, Inc. |
Amino diols useful in the treatment of alzheimer's disease
|
US20030129250A1
(en)
*
|
2001-11-20 |
2003-07-10 |
Advanced Inhalation Research Inc. |
Particulate compositions for improving solubility of poorly soluble agents
|
US7182961B2
(en)
*
|
2001-11-20 |
2007-02-27 |
Advanced Inhalation Research, Inc. |
Particulate compositions for pulmonary delivery
|
GB0127805D0
(en)
*
|
2001-11-20 |
2002-01-09 |
Smithkline Beecham Plc |
Pharmaceutical composition
|
UA76810C2
(uk)
†
|
2001-12-10 |
2006-09-15 |
Мерк Енд Ко., Інк. |
Фармацевтична композиція антагоніста рецептора тахікініну у формі наночастинок
|
CA2476755C
(en)
|
2001-12-17 |
2014-08-26 |
Corixa Corporation |
Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
|
MXPA04005865A
(es)
|
2001-12-19 |
2004-09-13 |
Nektar Therapeutics |
Suministro de aminoglucosidos a los pulmones.
|
JP2005513080A
(ja)
*
|
2001-12-20 |
2005-05-12 |
フェムファーマ, インコーポレイテッド |
薬物の膣送達
|
EP1458365A1
(en)
*
|
2001-12-21 |
2004-09-22 |
Celator Technologies Inc. |
Improved polymer-lipid delivery vehicles
|
US20030235619A1
(en)
*
|
2001-12-21 |
2003-12-25 |
Christine Allen |
Polymer-lipid delivery vehicles
|
EP1463502B1
(en)
|
2001-12-21 |
2011-07-13 |
Tibotec Pharmaceuticals |
Broadspectrum heterocyclic substituted phenyl containing sulfonamide hiv protease inhibitors
|
BR0207583A
(pt)
*
|
2001-12-26 |
2004-04-27 |
Genelabs Tech Inc |
Derivados de poliamida possuindo atividade antibacteriana, antifungo ou antitumor
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
JP2005515224A
(ja)
*
|
2002-01-14 |
2005-05-26 |
ダウ グローバル テクノロジーズ インコーポレイティド |
テンプレート乳剤からの薬剤ナノ粒子
|
IL162734A0
(en)
|
2002-02-01 |
2005-11-20 |
Ariad Gene Therapeutics Inc |
Phosphorus-containing compounds & uses thereof
|
EP1474144B1
(en)
*
|
2002-02-01 |
2008-08-06 |
Pfizer Products Inc. |
Controlled release pharmaceutical dosage forms of a cholesteryl ester transfer protein inhibitor
|
EP1471887B1
(en)
|
2002-02-04 |
2010-04-21 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having lysozyme as a surface stabilizer
|
US7026465B2
(en)
*
|
2002-02-15 |
2006-04-11 |
Corixa Corporation |
Fusion proteins of Mycobacterium tuberculosis
|
MY142238A
(en)
|
2002-03-12 |
2010-11-15 |
Tibotec Pharm Ltd |
Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors
|
GB0206200D0
(en)
*
|
2002-03-15 |
2002-05-01 |
Glaxo Group Ltd |
Pharmaceutical compositions
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
EP1800666A1
(en)
*
|
2002-03-20 |
2007-06-27 |
Elan Pharma International Limited |
Nanoparticulate compositions of angiogenesis inhibitors
|
JP4842514B2
(ja)
*
|
2002-03-20 |
2011-12-21 |
エラン ファーマ インターナショナル,リミティド |
血管新生抑制剤のナノ粒子組成物
|
EP1487419A2
(en)
*
|
2002-03-20 |
2004-12-22 |
Elan Pharma International Limited |
Fast dissolving dosage forms having reduced friability
|
PT1494732E
(pt)
|
2002-03-20 |
2008-03-20 |
Mannkind Corp |
Aparelho de inalação
|
AU2003230692A1
(en)
*
|
2002-03-20 |
2003-10-08 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of map kinase inhibitors
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
WO2003087763A2
(en)
|
2002-04-03 |
2003-10-23 |
Celltech R & D, Inc. |
Association of polymorphisms in the sost gene region with bone mineral density
|
US20040038303A1
(en)
*
|
2002-04-08 |
2004-02-26 |
Unger Gretchen M. |
Biologic modulations with nanoparticles
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US7101576B2
(en)
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
EP1494649B1
(en)
*
|
2002-04-12 |
2012-01-04 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
US7582284B2
(en)
|
2002-04-17 |
2009-09-01 |
Nektar Therapeutics |
Particulate materials
|
WO2003090717A1
(en)
*
|
2002-04-23 |
2003-11-06 |
Nanotherapeutics, Inc |
Process of forming and modifying particles and compositions produced thereby
|
DE10218109A1
(de)
*
|
2002-04-23 |
2003-11-20 |
Jenapharm Gmbh |
Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
|
US7262208B2
(en)
*
|
2002-04-30 |
2007-08-28 |
Elan Pharmaceuticals, Inc. |
Hydroxypropyl amides for the treatment of Alzheimer's disease
|
CA2484637A1
(en)
*
|
2002-05-06 |
2003-11-20 |
Elan Pharma International Ltd. |
Nanoparticulate nystatin formulations
|
KR20100130234A
(ko)
|
2002-05-17 |
2010-12-10 |
티보텍 파마슈티컬즈 |
광범위 스펙트럼의 치환된 벤즈이속사졸 설폰아미드 hiv 프로테아제 저해제
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US8313760B2
(en)
|
2002-05-24 |
2012-11-20 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
AU2003234670B2
(en)
*
|
2002-05-24 |
2010-06-10 |
Angiotech International Ag |
Compositions and methods for coating medical implants
|
JP4533134B2
(ja)
*
|
2002-06-10 |
2010-09-01 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子ポリコサノール製剤および新規なポリコサノールの組合せ
|
EP1531799A1
(en)
*
|
2002-06-10 |
2005-05-25 |
Elan Pharma International Limited |
Nanoparticulate formulations comprising hmg coa reductase inhibitor derivatives ("statins"), novel combinations thereof as well as manufacturing of these pharmaceutical compositions
|
EP1551457A1
(en)
|
2002-07-16 |
2005-07-13 |
Elan Pharma International Limited |
Liquid dosage compositions of stable nanoparticulate active agents
|
GB0216700D0
(en)
*
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
US20030017208A1
(en)
*
|
2002-07-19 |
2003-01-23 |
Francis Ignatious |
Electrospun pharmaceutical compositions
|
AR040588A1
(es)
*
|
2002-07-26 |
2005-04-13 |
Schering Corp |
Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
|
AU2002950426A0
(en)
*
|
2002-07-29 |
2002-09-12 |
Patrick John Shanahan |
Anti microbial oro-dental system
|
DE10234784A1
(de)
*
|
2002-07-30 |
2004-02-19 |
Günenthal GmbH |
Intravenös applizierbare, pharmazeutische Darreichungsform
|
US7838034B2
(en)
|
2002-07-30 |
2010-11-23 |
Grunenthal Gmbh |
Intravenous pharmaceutical form of administration
|
US20040023935A1
(en)
*
|
2002-08-02 |
2004-02-05 |
Dey, L.P. |
Inhalation compositions, methods of use thereof, and process for preparation of same
|
US20040028746A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Sonke Svenson |
Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
|
US20040028747A1
(en)
*
|
2002-08-06 |
2004-02-12 |
Tucker Christopher J. |
Crystalline drug particles prepared using a controlled precipitation process
|
MXPA05000977A
(es)
*
|
2002-08-12 |
2005-05-16 |
Pfizer Prod Inc |
Composiciones farmaceuticas de farmacos semiordenados y polimeros.
|
JP4681296B2
(ja)
|
2002-08-14 |
2011-05-11 |
テイボテク・フアーマシユーチカルズ・リミテツド |
スペクトルの広い置換オキシインドールスルホンアミドhivプロテアーゼ阻害剤
|
US7445796B2
(en)
*
|
2002-08-19 |
2008-11-04 |
L. Perrigo Company |
Pharmaceutically active particles of a monomodal particle size distribution and method
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
UY27939A1
(es)
|
2002-08-21 |
2004-03-31 |
Glaxo Group Ltd |
Compuestos
|
WO2004019873A2
(en)
*
|
2002-08-29 |
2004-03-11 |
Scios Inc. |
Methods of promoting osteogenesis
|
AU2003276688A1
(en)
*
|
2002-09-02 |
2004-03-19 |
Sun Pharmaceutical Industries Limited |
Pharmaceutical composition of metaxalone with enhanced oral bioavailability
|
DE60334924D1
(de)
*
|
2002-09-11 |
2010-12-23 |
Elan Pharma Int Ltd |
Anoteilchengrösse
|
AU2003302226A1
(en)
*
|
2002-09-24 |
2004-06-30 |
University Of Kentucky Research Foundation |
Nanoparticle-based vaccine delivery system containing adjuvant
|
US20040105778A1
(en)
*
|
2002-10-04 |
2004-06-03 |
Elan Pharma International Limited |
Gamma irradiation of solid nanoparticulate active agents
|
US20040105881A1
(en)
*
|
2002-10-11 |
2004-06-03 |
Gregor Cevc |
Aggregates with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
|
US20080145424A1
(en)
*
|
2002-10-24 |
2008-06-19 |
Enos Phramaceuticals, Inc. |
Sustained release L-arginine formulations and methods of manufacture and use
|
KR20050083827A
(ko)
*
|
2002-10-24 |
2005-08-26 |
이노스 파마슈티칼스, 인코포레이티드 |
서방성 l-아르기닌 포뮬레이션 및 이의 제조방법 및 용도
|
WO2004043456A1
(en)
*
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Cholesterol absorption inhibitors for the treatment of demyelination
|
JP4776233B2
(ja)
*
|
2002-11-12 |
2011-09-21 |
エラン ファーマ インターナショナル,リミティド |
摩損しにくくかつプルランを含む速崩壊性固形製剤
|
GB0227443D0
(en)
*
|
2002-11-25 |
2002-12-31 |
Glaxo Group Ltd |
Pyrimidine derivatives
|
US7351738B2
(en)
|
2002-11-27 |
2008-04-01 |
Elan Pharmaceuticals, Inc. |
Substituted ureas and carbamates
|
EP2982668A3
(en)
|
2002-12-03 |
2016-04-13 |
Pharmacyclics LLC |
2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors for the treatment of thromboembolic disorders
|
US20050095267A1
(en)
*
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
WO2004053107A2
(en)
*
|
2002-12-06 |
2004-06-24 |
Scios Inc. |
Methods for treating diabetes
|
US20040109826A1
(en)
*
|
2002-12-06 |
2004-06-10 |
Dey, L.P. |
Stabilized albuterol compositions and method of preparation thereof
|
BR0215979A
(pt)
*
|
2002-12-13 |
2005-11-01 |
Jagotec Ag |
Formulação de espironolactona nanoparticulada tópica, uso de nanossuspensões de espironolactona, sistema de rede cristalina, e, processo para a preparação de uma formulação de espironolactona nanoparticulada tópica
|
WO2004058216A2
(en)
*
|
2002-12-17 |
2004-07-15 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
AU2003299818A1
(en)
|
2002-12-20 |
2004-07-22 |
Applera Corporation |
Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof
|
GB0230087D0
(en)
*
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
GB0230088D0
(en)
*
|
2002-12-24 |
2003-01-29 |
Astrazeneca Ab |
Therapeutic agents
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
WO2004060322A2
(en)
*
|
2003-01-02 |
2004-07-22 |
Femmepharma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
RU2389732C2
(ru)
|
2003-01-06 |
2010-05-20 |
Корикса Корпорейшн |
Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
|
US7960522B2
(en)
|
2003-01-06 |
2011-06-14 |
Corixa Corporation |
Certain aminoalkyl glucosaminide phosphate compounds and their use
|
JP4469846B2
(ja)
*
|
2003-01-31 |
2010-06-02 |
エラン ファーマ インターナショナル,リミティド |
ナノ粒子状トピラメート製剤
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
GB0302671D0
(en)
*
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
GB0302673D0
(en)
*
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
GB0302672D0
(en)
*
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
CA2517573C
(en)
|
2003-03-07 |
2011-12-06 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
MXPA05009501A
(es)
|
2003-03-07 |
2005-10-18 |
Schering Corp |
Compuestos de azetidinona sustituidos, formulaciones y usos de los mismos para el tratamiento de hipercolesterolemia.
|
JP5137228B2
(ja)
|
2003-03-07 |
2013-02-06 |
メルク・シャープ・アンド・ドーム・コーポレーション |
高コレステロール血症の処置のための置換アゼチジノン化合物、置換アゼチジノン処方物およびそれらの使用
|
US20040184995A1
(en)
*
|
2003-03-17 |
2004-09-23 |
Yamanouchi Pharmaceutical Co., Ltd. |
Novel dry powder inhalation for lung-delivery and manufacturing method thereof
|
ES2665464T3
(es)
*
|
2003-03-28 |
2018-04-25 |
Sigmoid Pharma Limited |
Forma de dosificación oral sólida que contiene microcápsulas sin costuras
|
US8747908B2
(en)
|
2003-04-09 |
2014-06-10 |
Osmose, Inc. |
Micronized wood preservative formulations
|
US8637089B2
(en)
|
2003-04-09 |
2014-01-28 |
Osmose, Inc. |
Micronized wood preservative formulations
|
SG163438A1
(en)
|
2003-04-09 |
2010-08-30 |
Osmose Inc |
Micronized wood preservative formulations
|
EP1615915A1
(en)
*
|
2003-04-21 |
2006-01-18 |
Elan Pharmaceuticals, Inc. |
Phenacyl 2-hydroxy-3-diaminoalkanes
|
CA2523232A1
(en)
|
2003-04-21 |
2004-11-04 |
Elan Pharmaceuticals, Inc. |
(hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
|
MXPA05012467A
(es)
*
|
2003-05-19 |
2006-02-22 |
Baxter Int |
Particulas solidas que comprenden un anticonvulsivo o un inmunosupresor revestido con uno o mas modificadores de superficie.
|
FR2855051B1
(fr)
*
|
2003-05-20 |
2006-08-25 |
Oreal |
Particules stabilisees en taille par copolymere diacide
|
WO2004103345A2
(fr)
*
|
2003-05-20 |
2004-12-02 |
L'oreal |
Particules stabilisees en taille par copolymere diacide
|
CA2526454C
(en)
*
|
2003-05-22 |
2013-08-13 |
Applied Nanosystems B.V. |
Gel-assisted production of small particles
|
WO2004105809A1
(en)
*
|
2003-05-22 |
2004-12-09 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
US7459146B2
(en)
*
|
2003-05-30 |
2008-12-02 |
3M Innovative Properties Company |
Stabilized aerosol dispersions
|
US7109247B2
(en)
*
|
2003-05-30 |
2006-09-19 |
3M Innovative Properties Company |
Stabilized particle dispersions containing nanoparticles
|
DE10325989A1
(de)
*
|
2003-06-07 |
2005-01-05 |
Glatt Gmbh |
Verfahren zur Herstellung von und daraus resultierende Mikropellets sowie deren Verwendung
|
ES2586401T3
(es)
|
2003-06-16 |
2016-10-14 |
Ucb Pharma S.A. |
Anticuerpos específicos para la esclerostina y métodos para aumentar la mineralización ósea
|
DE602004022171D1
(de)
|
2003-06-17 |
2009-09-03 |
Phibrowood Llc |
Teilchenförmiges holzschutzmittel und herstellungsverfahren dafür
|
WO2004111033A1
(en)
*
|
2003-06-18 |
2004-12-23 |
Astrazeneca Ab |
2-substitued 5, 6-diaryl-pyrazine derivatives as cb1 modulator.
|
GB0314057D0
(en)
*
|
2003-06-18 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
GB0314261D0
(en)
*
|
2003-06-19 |
2003-07-23 |
Astrazeneca Ab |
Therapeutic agents
|
AU2004249172A1
(en)
*
|
2003-06-24 |
2004-12-29 |
Baxter International Inc. |
Specific delivery of drugs to the brain
|
US8986736B2
(en)
*
|
2003-06-24 |
2015-03-24 |
Baxter International Inc. |
Method for delivering particulate drugs to tissues
|
TWI359675B
(en)
*
|
2003-07-10 |
2012-03-11 |
Dey L P |
Bronchodilating β-agonist compositions
|
US8308682B2
(en)
|
2003-07-18 |
2012-11-13 |
Broncus Medical Inc. |
Devices for maintaining patency of surgically created channels in tissue
|
US20050042177A1
(en)
*
|
2003-07-23 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel compositions of sildenafil free base
|
CN100428959C
(zh)
*
|
2003-08-06 |
2008-10-29 |
卫材R&D管理有限公司 |
用于制备药物超微粒子的方法和装置
|
DE602004018150D1
(de)
*
|
2003-08-08 |
2009-01-15 |
Elan Pharma Int Ltd |
Neue metaxalon-zusammensetzungen
|
US7419996B2
(en)
*
|
2003-08-13 |
2008-09-02 |
The University Of Houston |
Parenteral and oral formulations of benzimidazoles
|
GB0319797D0
(en)
*
|
2003-08-26 |
2003-09-24 |
Leuven K U Res & Dev |
Particle size reduction of poorly soluble drugs
|
US20070190129A1
(en)
*
|
2003-09-02 |
2007-08-16 |
Pfizer Inc. |
Sustained release dosage forms of ziprasidone
|
US9149440B2
(en)
*
|
2003-09-02 |
2015-10-06 |
University Of South Florida |
Nanoparticles for drug-delivery
|
US8268885B2
(en)
|
2003-09-11 |
2012-09-18 |
Janssen R&D Ireland |
Entry inhibitors of the HIV virus
|
GB0327723D0
(en)
*
|
2003-09-15 |
2003-12-31 |
Vectura Ltd |
Pharmaceutical compositions
|
US8617467B2
(en)
|
2003-09-22 |
2013-12-31 |
Baxter International Inc. |
High-pressure sterilization to terminally sterilize pharmaceutical preparations and medical products
|
JP2007521324A
(ja)
*
|
2003-09-29 |
2007-08-02 |
エノス ファーマシューティカルズ, インク. |
徐放性l−アルギニン調合物並びにその製造法及び使用法
|
US20060019971A1
(en)
*
|
2003-09-30 |
2006-01-26 |
Higgins Linda S |
Treatment of cardiovascular disease with inhibitors of p38 kinase
|
ATE357442T1
(de)
*
|
2003-10-16 |
2007-04-15 |
Teva Pharma |
Verfahren zur herstellung von candesartan cilexetil
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
EP1684725A1
(en)
*
|
2003-10-31 |
2006-08-02 |
Elan Pharma International Limited |
Novel nimesulide compositions
|
WO2005046797A2
(en)
*
|
2003-11-05 |
2005-05-26 |
Schering Corporation |
Combinations of lipid modulating agents and substituted azetidinones and treatments for vascular conditions
|
CA2544627A1
(en)
*
|
2003-11-05 |
2005-05-19 |
Elan Pharma International Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
JP2007516742A
(ja)
*
|
2003-11-20 |
2007-06-28 |
アンジオテック インターナショナル アーゲー |
電気装置と瘢痕化抑制剤
|
CZ300438B6
(cs)
*
|
2003-11-25 |
2009-05-20 |
Pliva Hrvatska D.O.O. |
Zpusob prípravy orální pevné lékové formy s okamžitým uvolnováním úcinné látky obsahující jako úcinnou látku polymorfní formu finasteridu
|
EP2386656B1
(en)
|
2003-11-26 |
2013-04-24 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US20050258288A1
(en)
*
|
2003-11-26 |
2005-11-24 |
E. I. Du Pont De Nemours And Company |
High pressure media milling system and process of forming particles
|
EP1688169A4
(en)
*
|
2003-11-28 |
2008-10-01 |
Mitsubishi Chem Corp |
METHOD FOR PRODUCING FINE PARTICLES OF AN ORGANIC COMPOUND
|
ES2562778T3
(es)
*
|
2003-12-02 |
2016-03-08 |
The Ohio State University Research Foundation |
Ácidos grasos de cadena corta unidos a motivos quelantes de Zn2+ como una clase novedosa de inhibidores de histona deacetilasa
|
KR100603974B1
(ko)
|
2003-12-05 |
2006-07-25 |
김갑식 |
고체상 지질을 용매로 이용한 나노수준의 또는 비결정질입자의 제조 방법
|
ES2584867T3
(es)
*
|
2004-01-12 |
2016-09-29 |
Mannkind Corporation |
Un método que reduce los niveles séricos de proinsulina en diabéticos de tipo 2
|
CA2553973A1
(en)
*
|
2004-01-21 |
2005-08-04 |
Elan Pharmaceuticals, Inc. |
Methods of treatment of amyloidosis using aspartyl-protease inihibitors
|
US8957034B2
(en)
*
|
2004-01-28 |
2015-02-17 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
US20050169978A1
(en)
*
|
2004-01-29 |
2005-08-04 |
Shu-Wen Fu |
Wet-micro grinding
|
KR20060135729A
(ko)
*
|
2004-01-29 |
2006-12-29 |
백스터 인터내셔널 인코포레이티드 |
중추신경계 전달 증가를 위한 항레트로바이러스제의나노현탁액
|
WO2005077941A2
(en)
*
|
2004-02-11 |
2005-08-25 |
Teva Pharmaceutical Industries Ltd. |
Candesartan cilexetil polymorphs
|
WO2005087215A1
(en)
*
|
2004-03-09 |
2005-09-22 |
Elan Pharmaceuticals, Inc. |
Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
|
JP2007528402A
(ja)
*
|
2004-03-09 |
2007-10-11 |
エラン ファーマシューティカルズ,インコーポレイテッド |
置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
|
US20060014737A1
(en)
*
|
2004-03-09 |
2006-01-19 |
Varghese John |
Methods of treatment of amyloidosis using bi-aryl aspartyl protease inhibitors
|
CA2558034A1
(en)
*
|
2004-03-09 |
2005-09-22 |
Elan Pharmaceuticals, Inc. |
Substituted hydroxyethylamine aspartyl protease inhibitors
|
WO2005087714A2
(en)
*
|
2004-03-09 |
2005-09-22 |
Elan Pharmaceuticals, Inc. |
Methods of treatment of amyloidosis using bi-cyclic aspartyl protease inhibitors
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
ATE446581T1
(de)
*
|
2004-03-12 |
2009-11-15 |
Trinity College Dublin |
Magnetoresistives medium
|
US20050202051A1
(en)
*
|
2004-03-15 |
2005-09-15 |
Chinea Vanessa I. |
Pharmaceutical vehicle
|
US20050203482A1
(en)
*
|
2004-03-15 |
2005-09-15 |
Chinea Vanessa I. |
Pharmaceutical dispensing apparatus and method
|
KR20060135000A
(ko)
*
|
2004-03-30 |
2006-12-28 |
스미스클라인 비참 코포레이션 |
분무 건조 제약 조성물
|
JP4875979B2
(ja)
*
|
2004-03-31 |
2012-02-15 |
富山化学工業株式会社 |
難溶性薬物の微粒子分散液およびその製造方法
|
AR048650A1
(es)
|
2004-05-04 |
2006-05-10 |
Tibotec Pharm Ltd |
Derivados de (1,10b-dihidro-2-(aminocarbonil-fenil)-5h-pirazolo[1,5 c][1,3]benzoxazin-5-il)fenil metanona como inhibidores de la replicacion viral del vih
|
CN1953973A
(zh)
*
|
2004-05-05 |
2007-04-25 |
特瓦制药工业有限公司 |
高纯度坎地沙坦酯的制备
|
CN1997363B
(zh)
|
2004-05-07 |
2012-03-28 |
塞阔伊亚药品公司 |
抗耐药性反转录病毒蛋白酶抑制剂
|
CA2852855C
(en)
|
2004-05-07 |
2016-07-05 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis methods of detection and uses thereof
|
BRPI0511267A
(pt)
|
2004-05-17 |
2007-11-27 |
Tibotec Pharm Ltd |
1,5-diidropirido[3,2-b]indol-2-onas 4-substituìdas
|
US7316738B2
(en)
|
2004-10-08 |
2008-01-08 |
Phibro-Tech, Inc. |
Milled submicron chlorothalonil with narrow particle size distribution, and uses thereof
|
BRPI0511173A
(pt)
|
2004-05-17 |
2007-12-04 |
Tibotec Pharm Ltd |
1-fenil-1,5-diidro-pirido-(3,2b)indol-2-onas substituìdas nas posições 6,7,8,9, de utilidade como agentes farmacêuticos antiinfecciosos
|
US20050252408A1
(en)
*
|
2004-05-17 |
2005-11-17 |
Richardson H W |
Particulate wood preservative and method for producing same
|
EA012330B1
(ru)
|
2004-05-17 |
2009-08-28 |
Тиботек Фармасьютикалз Лтд. |
1-ГЕТЕРОЦИКЛИЛ-1,5-ДИГИДРОПИРИДО[3,2-b]ИНДОЛ-2-ОНЫ
|
US20080199493A1
(en)
|
2004-05-25 |
2008-08-21 |
Picker Louis J |
Siv and Hiv Vaccination Using Rhcmv- and Hcmv-Based Vaccine Vectors
|
JP2008500288A
(ja)
*
|
2004-05-28 |
2008-01-10 |
イメイジノット ピーティーワイ エルティーディー |
経口治療用化合物の供給系
|
US8216610B2
(en)
*
|
2004-05-28 |
2012-07-10 |
Imaginot Pty Ltd. |
Oral paracetamol formulations
|
WO2005117997A1
(en)
*
|
2004-06-01 |
2005-12-15 |
The Ohio State University |
Ligands having metal binding ability and targeting properties
|
US8012457B2
(en)
|
2004-06-04 |
2011-09-06 |
Acusphere, Inc. |
Ultrasound contrast agent dosage formulation
|
KR20070037444A
(ko)
*
|
2004-06-15 |
2007-04-04 |
백스터 인터내셔널 인코포레이티드 |
고체 미립자성 치료제의 생체외 적용방법
|
WO2006002088A2
(en)
*
|
2004-06-21 |
2006-01-05 |
The Ohio State University Research Foundation |
Amino-quinazoline derivatives as antitumor agents
|
EP1773756A2
(en)
*
|
2004-07-09 |
2007-04-18 |
Elan Pharmaceuticals, Inc. |
Oxime derivative substituted hydroxyethylamine aspartyl protease inhibitors
|
JP2008505929A
(ja)
*
|
2004-07-09 |
2008-02-28 |
エラン ファーマシューティカルズ,インコーポレイテッド |
オキシム誘導体ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
|
CA2574767C
(en)
|
2004-07-19 |
2015-02-17 |
Celator Pharmaceuticals, Inc. |
Particulate constructs for release of active agents
|
US8409167B2
(en)
|
2004-07-19 |
2013-04-02 |
Broncus Medical Inc |
Devices for delivering substances through an extra-anatomic opening created in an airway
|
ES2414861T3
(es)
*
|
2004-08-18 |
2013-07-23 |
Kadmon Corporation, Llc |
Uso del FTS para el tratamiento de trastornos malignos
|
CA2577583A1
(en)
*
|
2004-08-19 |
2006-03-02 |
Alza Corporation |
Controlled release nanoparticle active agent formulation dosage forms and methods
|
CN101010305B
(zh)
|
2004-08-20 |
2010-08-11 |
曼金德公司 |
二酮哌嗪合成的催化反应
|
MX2007002189A
(es)
|
2004-08-23 |
2008-01-11 |
Mannkind Corp |
Sales de dicetopiperazina, sales de dicetomorfolina o sales de dicetodioxano para suministro de farmacos.
|
GB0418791D0
(en)
*
|
2004-08-23 |
2004-09-22 |
Glaxo Group Ltd |
Novel process
|
US20060074098A1
(en)
*
|
2004-08-27 |
2006-04-06 |
Roy Hom |
Methods of treatment of amyloidosis using ethanolcyclicamine aspartyl protease inhibitors
|
US9061027B2
(en)
*
|
2004-08-27 |
2015-06-23 |
Board Of Regents, The University Of Texas System |
Enhanced delivery of drug compositions to treat life threatening infections
|
EP1797934A4
(en)
*
|
2004-09-07 |
2009-09-02 |
Mitsubishi Chem Corp |
METHOD FOR MANUFACTURING FINULY PARTICULATE SUBSTANCE AND FINALLY PARTICULATE SUBSTANCE
|
US20080171687A1
(en)
*
|
2004-09-16 |
2008-07-17 |
Abraxis Bioscience, Inc. |
Compositions And Methods For The Preparation And Administration Of Poorly Water Soluble Drugs
|
US20080020018A1
(en)
*
|
2004-09-27 |
2008-01-24 |
Joey Moodley |
Combination Products
|
US7426948B2
(en)
*
|
2004-10-08 |
2008-09-23 |
Phibrowood, Llc |
Milled submicron organic biocides with narrow particle size distribution, and uses thereof
|
AU2005296077B2
(en)
|
2004-10-14 |
2010-12-23 |
Koppers Performance Chemicals Inc. |
Micronized wood preservative formulations in organic carriers
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
US20080095722A1
(en)
*
|
2004-11-12 |
2008-04-24 |
Idea Ag |
Extended Surface Aggregates in the Treatment of Skin Conditions
|
EP2623095A1
(en)
*
|
2004-11-16 |
2013-08-07 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
US20090155331A1
(en)
*
|
2005-11-16 |
2009-06-18 |
Elan Pharma International Limited |
Injectable nanoparticulate olanzapine formulations
|
WO2006121468A1
(en)
*
|
2004-11-22 |
2006-11-16 |
Genelabs Technologies, Inc. |
5-nitro-nucleoside compounds for treating viral infections
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
JPWO2006062238A1
(ja)
*
|
2004-12-07 |
2008-06-12 |
味の素株式会社 |
アミノ酸の微粉末及びその懸濁液
|
WO2006062875A1
(en)
*
|
2004-12-08 |
2006-06-15 |
Merck & Co., Inc. |
Ophthalmic nanoparticulate formulation of a cyclooxygenase-2 selective inhibitor
|
MX2007007342A
(es)
*
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Formulaciones de tacrolimus nanoparticuladas.
|
WO2006073061A1
(ja)
*
|
2004-12-17 |
2006-07-13 |
Mitsubishi Chemical Corporation |
新規なコアーシェル構造体
|
US20060159767A1
(en)
*
|
2004-12-22 |
2006-07-20 |
Elan Pharma International Limited |
Nanoparticulate bicalutamide formulations
|
AU2012201630B8
(en)
*
|
2004-12-31 |
2014-03-06 |
Iceutica Pty Ltd |
NanoParticle Composition(s) and Method for Synthesis Thereof
|
EP1830824B1
(en)
*
|
2004-12-31 |
2016-01-13 |
Iceutica Pty Ltd. |
Nanoparticle composition and methods for synthesis thereof
|
AU2005321751B2
(en)
*
|
2004-12-31 |
2012-04-05 |
Iceutica Pty Ltd |
Nanoparticle composition and methods for synthesis thereof
|
CA2594332A1
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
JPWO2006073154A1
(ja)
*
|
2005-01-07 |
2008-06-12 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
医薬組成物及びその製造方法
|
US8623405B2
(en)
*
|
2005-01-28 |
2014-01-07 |
Takeda Pharmaceutical Company Limited |
Finely divided composition containing poorly water soluble substance
|
ES2265262B1
(es)
*
|
2005-01-31 |
2008-03-01 |
Activery Biotech, S.L.(Titular Al 50%) |
Procedimiento para la obtencion de sistemas micro- y nanodispersos.
|
WO2006086402A2
(en)
|
2005-02-08 |
2006-08-17 |
Research Development Foundation |
Compositions and methods related to soluble g-protein coupled receptors(sgpcrs)
|
CN101189001A
(zh)
|
2005-02-15 |
2008-05-28 |
伊兰制药国际有限公司 |
纳米微粒苯并二氮杂䓬气雾剂及注射剂
|
CA2597683A1
(en)
*
|
2005-02-28 |
2006-09-08 |
Genelabs Technologies, Inc. |
Tricyclic-nucleoside prodrugs for treating viral infections
|
AU2005100176A4
(en)
*
|
2005-03-01 |
2005-04-07 |
Gym Tv Pty Ltd |
Garbage bin clip
|
EP1855651A4
(en)
*
|
2005-03-03 |
2011-06-15 |
Elan Pharma Int Ltd |
NANOPARTICULAR COMPOSITIONS OF HETEROCYCLIC AMIDE DERIVATIVES
|
WO2006099121A2
(en)
*
|
2005-03-10 |
2006-09-21 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride and tamsulosin hydrochloride, and mixtures thereof
|
EP2113572B1
(en)
|
2005-03-11 |
2012-12-05 |
Celera Corporation |
Genetic polymorphisms associated with coronary heart disease, methods of detection and uses thereof
|
EA200701987A1
(ru)
*
|
2005-03-16 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Составы из нанодисперсного антагониста лейкотриеновых рецепторов/кортикостероида
|
NZ561666A
(en)
*
|
2005-03-17 |
2010-05-28 |
Elan Pharma Int Ltd |
Nanoparticulate biphosphonate compositions
|
MX2007011772A
(es)
*
|
2005-03-23 |
2007-12-05 |
Elan Pharma Int Ltd |
Formulaciones de antihistaminico y corticosteroide de materia en nanoparticulas.
|
US20070224282A1
(en)
*
|
2005-03-28 |
2007-09-27 |
Toyama Chemical Co., Ltd. |
Fine Dispersion of Sparingly Soluble Drug and Process for Producing the Same
|
EP1868641A2
(en)
|
2005-03-31 |
2007-12-26 |
GlaxoSmithKline Biologicals SA |
Vaccines against chlamydial infection
|
TW200710091A
(en)
|
2005-04-11 |
2007-03-16 |
Tibotec Pharm Ltd |
(1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
WO2006110811A1
(en)
*
|
2005-04-12 |
2006-10-19 |
Elan Pharma International Limited |
Nanoparticulate quinazoline derivative formulations
|
US7825087B2
(en)
*
|
2005-04-12 |
2010-11-02 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
EP1874272A4
(en)
*
|
2005-04-13 |
2010-11-10 |
Elan Pharma Int Ltd |
NANOTEHOUS COMPOSITIONS FROM PROSTAGLANDIN DERIVATIVES WITH CONTROLLED RELEASE
|
JP2008538751A
(ja)
*
|
2005-04-13 |
2008-11-06 |
ファイザー・プロダクツ・インク |
ナノ粒子組成物を持続放出するための注射用デポ製剤および方法
|
US20080305161A1
(en)
*
|
2005-04-13 |
2008-12-11 |
Pfizer Inc |
Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
|
EP1868574B1
(de)
*
|
2005-04-13 |
2010-01-06 |
Abbott GmbH & Co. KG |
Verfahren zur schonenden herstellung hochfeiner partikelsuspensionen und hochfeiner partikel sowie deren verwendung
|
ITMI20050739A1
(it)
*
|
2005-04-22 |
2006-10-23 |
Effebi Spa |
Piastrina di connsessione valvola-attuatore
|
WO2006116557A1
(en)
*
|
2005-04-25 |
2006-11-02 |
Genelabs Technologies, Inc. |
Nucleoside compounds for treating viral infections
|
KR20130110233A
(ko)
|
2005-04-29 |
2013-10-08 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
결핵균 감염을 예방 또는 치료하기 위한 신규한 방법
|
US7592429B2
(en)
*
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
US8003108B2
(en)
|
2005-05-03 |
2011-08-23 |
Amgen Inc. |
Sclerostin epitopes
|
JP2008540550A
(ja)
*
|
2005-05-10 |
2008-11-20 |
エラン・ファルマ・インターナショナル・リミテッド |
ビタミンk2を含むナノ粒子および制御放出組成物
|
DE202006020979U1
(de)
*
|
2005-05-10 |
2011-08-05 |
Teva Pharmaceutical Industries Ltd. |
Stabiles mikronisiertes Candesartan-Cilexetil
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
CA2607494A1
(en)
*
|
2005-05-10 |
2007-08-02 |
Elan Pharma International Limited |
Nanoparticulate clopidogrel formulations
|
JP2008540691A
(ja)
*
|
2005-05-16 |
2008-11-20 |
エラン・ファルマ・インターナショナル・リミテッド |
セファロスポリンを含むナノ粒子および放出制御組成物
|
EP1937218A2
(en)
*
|
2005-05-23 |
2008-07-02 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising a platelet aggregation inhibitor
|
CN101232870A
(zh)
|
2005-06-03 |
2008-07-30 |
伊兰制药国际有限公司 |
纳米微粒甲磺酸伊马替尼制剂
|
WO2007053197A2
(en)
*
|
2005-06-03 |
2007-05-10 |
Elan Pharma International, Limited |
Nanoparticulate acetaminophen formulations
|
US20070042049A1
(en)
*
|
2005-06-03 |
2007-02-22 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
ES2400772T3
(es)
*
|
2005-06-07 |
2013-04-12 |
Ramot At Tel Aviv University Ltd. |
Sales novedosas de fármacos psicotrópicos conjugados y procedimientos para la preparación de las mismas
|
JP2009517485A
(ja)
*
|
2005-06-08 |
2009-04-30 |
エラン・ファルマ・インターナショナル・リミテッド |
セフジトレンを含むナノ粒子状および制御放出組成物
|
ATE446742T1
(de)
*
|
2005-06-09 |
2009-11-15 |
Elan Pharma Int Ltd |
Nanopartikuläre ebastinformulierungen
|
CN101237868A
(zh)
*
|
2005-06-13 |
2008-08-06 |
伊兰制药国际有限公司 |
纳米粒氯吡格雷和阿司匹林组合制剂
|
JP2008543862A
(ja)
*
|
2005-06-15 |
2008-12-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アゼルニジピン製剤
|
CA2613474A1
(en)
*
|
2005-06-20 |
2007-03-08 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising aryl-heterocyclic compounds
|
JP2008546796A
(ja)
*
|
2005-06-22 |
2008-12-25 |
エラン ファーマ インターナショナル リミテッド |
ナノ微粒子メゲストロール製剤
|
CA2613261A1
(en)
*
|
2005-06-24 |
2006-12-28 |
Genelabs Technologies, Inc. |
Heteroaryl derivatives for treating viruses
|
US20090028950A1
(en)
*
|
2005-06-29 |
2009-01-29 |
Mitsubishi Chemical Corporation |
Granule dispersion composition, process for producing the same, and granular material and medicine
|
EP1904053B1
(en)
*
|
2005-06-29 |
2011-08-17 |
DSM IP Assets B.V. |
Isoflavone nanoparticles and use thereof
|
EP1922150A1
(en)
*
|
2005-07-07 |
2008-05-21 |
Nanotherapeutics, Inc. |
Process for milling and preparing powders and compositions produced thereby
|
US20070298109A1
(en)
*
|
2005-07-07 |
2007-12-27 |
The Trustees Of The University Of Pennsylvania |
Nano-scale devices
|
WO2007008537A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
AU2006269961B2
(en)
*
|
2005-07-15 |
2012-07-19 |
Map Pharmaceuticals, Inc. |
Multiple active pharmaceutical ingredients combined in discrete inhalation particles and formulations thereof
|
WO2007016597A2
(en)
*
|
2005-07-29 |
2007-02-08 |
The Regents Of The University Of California |
Targeting tnf-alpha converting enzyme (tace)-dependent growth factor shedding in cancer therapy
|
US20080213385A1
(en)
*
|
2005-08-10 |
2008-09-04 |
Oskar Kalb |
Formulations for 7- (T-Butoxy) Iminomethyl Camptothecin
|
AR055602A1
(es)
*
|
2005-08-10 |
2007-08-29 |
Novartis Ag |
Una composicion farmaceutica de microparticulas de 7-terbutoxi-imino-metil-camptotecina
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
US20080193534A1
(en)
*
|
2005-08-12 |
2008-08-14 |
Astrazeneca Ab |
Process
|
ES2719093T3
(es)
*
|
2005-08-31 |
2019-07-08 |
Abraxis Bioscience Llc |
Composiciones de fármacos poco solubles en agua con mayor estabilidad y métodos para su preparación
|
SI1931321T1
(sl)
|
2005-08-31 |
2019-07-31 |
Abraxis Bioscience, Llc |
Sestave, ki zajemajo slabo vodotopne farmacevtske učinkovine in antimikrobna sredstva
|
EP1923051A4
(en)
*
|
2005-09-06 |
2012-12-19 |
Astellas Pharma Inc |
MICROPARTICLES OF A HEAVY-DUTY SUBSTANCE WITH ENTERIAN BASE MATERIAL ADSORBED ON THE SUBSTANCE SURFACE
|
US20070104792A1
(en)
*
|
2005-09-13 |
2007-05-10 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
RU2394550C2
(ru)
|
2005-09-14 |
2010-07-20 |
Маннкайнд Корпорейшн |
Способ получения лекарственной композиции, основанный на увеличении сродства поверхностей кристаллических микрочастиц к активным агентам
|
JP2009508859A
(ja)
*
|
2005-09-15 |
2009-03-05 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子アリピプラゾール製剤
|
US7799530B2
(en)
|
2005-09-23 |
2010-09-21 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular disorders and drug response, methods of detection and uses thereof
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070086952A1
(en)
*
|
2005-09-29 |
2007-04-19 |
Biodel, Inc. |
Rapid Acting and Prolonged Acting Inhalable Insulin Preparations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US20070077309A1
(en)
*
|
2005-09-30 |
2007-04-05 |
Wong Patrick S |
Banded controlled release nanoparticle active agent formulation dosage forms and methods
|
EP2322523B1
(en)
|
2005-10-07 |
2019-01-02 |
Exelixis, Inc. |
Process for the preparation of Pyridopyrimidinone Inhibitors of PI3Kalpha
|
EA019255B1
(ru)
|
2005-10-07 |
2014-02-28 |
Экселиксис, Инк. |
Ингибиторы фосфатидилинозит-3-киназы и содержащие их фармацевтические композиции
|
CA2624904A1
(en)
*
|
2005-10-12 |
2007-04-26 |
Elan Pharmaceuticals, Inc. |
Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
|
WO2007047305A1
(en)
*
|
2005-10-12 |
2007-04-26 |
Elan Pharmaceuticals, Inc. |
Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
|
US7695911B2
(en)
|
2005-10-26 |
2010-04-13 |
Celera Corporation |
Genetic polymorphisms associated with Alzheimer's Disease, methods of detection and uses thereof
|
DE102005053862A1
(de)
*
|
2005-11-04 |
2007-05-10 |
Pharmasol Gmbh |
Verfahren und Vorrichtung zur Herstellung hochfeiner Partikel sowie zur Beschichtung solcher Partikel
|
CN101360422B
(zh)
|
2005-11-23 |
2013-10-23 |
得克萨斯大学体系董事会 |
致癌Ras特异性细胞毒化合物及其使用方法
|
AU2006318349B2
(en)
|
2005-11-28 |
2010-08-19 |
Marinus Pharmaceuticals |
Ganaxolone formulations and methods for the making and use thereof
|
CA2629904C
(en)
*
|
2005-11-28 |
2018-07-10 |
Imaginot Pty Ltd. |
Oral therapeutic compound delivery system
|
WO2007064912A2
(en)
*
|
2005-12-02 |
2007-06-07 |
Elan Pharma International Limited |
Mometasone compositions and methods of making and using the same
|
RU2008128452A
(ru)
*
|
2005-12-12 |
2010-01-20 |
Дженелабс Текнолоджис, Инк. (Us) |
Соединения n-(6-членных арил)-амидов, фармацевтическая композиция с противовирусной активностью на их основе, способ лечения или профилактики вирусной инфекции с их помощью и способ их получения
|
US20070160542A1
(en)
*
|
2005-12-20 |
2007-07-12 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070185066A1
(en)
*
|
2005-12-20 |
2007-08-09 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070249572A1
(en)
*
|
2005-12-20 |
2007-10-25 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids
|
US20070178049A1
(en)
*
|
2005-12-20 |
2007-08-02 |
Verus Pharmaceuticals, Inc. |
Systems and methods for the delivery of corticosteroids having an enhanced pharmacokinetic profile
|
US20070197486A1
(en)
*
|
2005-12-20 |
2007-08-23 |
Verus Pharmaceuticals, Inc. |
Methods and systems for the delivery of corticosteroids
|
WO2007089335A2
(en)
|
2005-12-29 |
2007-08-09 |
Lexicon Pharmaceutical Inc. |
Multicyclic amino acid derivatives and methods of their use
|
US20090081157A1
(en)
|
2006-01-09 |
2009-03-26 |
Richard Syd Kornbluth |
Immunostimulatory Combinations for Vaccine Adjuvants
|
EP1988880A2
(en)
*
|
2006-02-15 |
2008-11-12 |
Tika Läkemedel AB |
Stable mixture of corticosteroids
|
ES2647080T3
(es)
|
2006-02-22 |
2017-12-19 |
Mannkind Corporation |
Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo
|
US7476405B2
(en)
*
|
2006-02-23 |
2009-01-13 |
Iomedix Sleep International Srl |
Compositions and methods for the induction and maintenance of quality sleep
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US20090099175A1
(en)
*
|
2006-03-01 |
2009-04-16 |
Arrington Mark P |
Phosphodiesterase 10 inhibitors
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
US20070264349A1
(en)
*
|
2006-03-07 |
2007-11-15 |
Novavax, Inc. |
Nano-structured compositions and methods of making and using the same
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
KR20080110807A
(ko)
*
|
2006-03-14 |
2008-12-19 |
머크 앤드 캄파니 인코포레이티드 |
마이크로 분쇄 및 마이크로-시드상의 결정화에 의한 결정성유기 미세입자 조성물의 생성 방법과 장치 및 이의 용도
|
JP2009534311A
(ja)
|
2006-04-03 |
2009-09-24 |
テイボテク・フアーマシユーチカルズ・リミテツド |
HIV阻害性3,4−ジヒドロ−イミダゾ[4,5−b]ピリジン−5−オン
|
JP2009533471A
(ja)
*
|
2006-04-12 |
2009-09-17 |
バイオデル, インコーポレイテッド |
即効型および長時間作用型組合せインスリン製剤
|
WO2008054508A2
(en)
*
|
2006-04-13 |
2008-05-08 |
Alza Corporation |
Stable nanosized amorphous drug
|
MX2008013427A
(es)
|
2006-04-19 |
2008-11-04 |
Novartis Ag |
Compuestos de benzoxazole y benzotiazole sustituidos-6-0 y metodos para inhibir la señalizacion csf-1r.
|
JP2007306950A
(ja)
*
|
2006-05-15 |
2007-11-29 |
Osaka Univ |
薬効成分ナノ粒子分散液の製造方法
|
US20070275052A1
(en)
*
|
2006-05-24 |
2007-11-29 |
Glenmark Pharmaceuticals Limited |
Pharmaceutical compositions containing sterol inhibitors
|
EP2040675A1
(en)
*
|
2006-05-30 |
2009-04-01 |
Elan Pharma International Limited |
Nanoparticulate posaconazole formulations
|
US20130197527A1
(en)
*
|
2006-06-12 |
2013-08-01 |
Smith & Nephew, Inc. |
Systems, methods and devices for tibial resection
|
EP2037914B1
(en)
*
|
2006-06-14 |
2013-10-23 |
Intervet International BV |
A suspension comprising benzimidazole carbamate and a polysorbate
|
AP2618A
(en)
|
2006-06-23 |
2013-03-18 |
Tibotec Pharmaceutical Ltd |
Aqueous suspensions of TMC278
|
WO2008002485A2
(en)
*
|
2006-06-23 |
2008-01-03 |
Alza Corporation |
Increased amorphous stability of poorly water soluble drugs by nanosizing
|
RU2009102262A
(ru)
*
|
2006-06-26 |
2010-08-10 |
Мьючуал Фармасьютикал Компани, Инк. (Us) |
Композиции активного агента, способы их получения и способы применения
|
KR101288781B1
(ko)
|
2006-06-28 |
2013-07-22 |
암젠 인크 |
글리신 수송자-1 억제제
|
BRPI0713053A2
(pt)
*
|
2006-06-30 |
2012-07-17 |
Iceutica Pty Ltd |
métodos para a preparação de compostos biologicamente ativos na forma nanoparticulada
|
JP5508003B2
(ja)
*
|
2006-06-30 |
2014-05-28 |
アイスイティカ ピーティーワイ リミテッド |
ナノ粒子状の形態における生物学的に活性な化合物の調製のための方法
|
WO2008008733A2
(en)
*
|
2006-07-10 |
2008-01-17 |
Elan Pharma International Ltd. |
Nanoparticulate sorafenib formulations
|
CN101511388B
(zh)
*
|
2006-07-17 |
2012-10-24 |
特拉维夫大学拉莫特有限公司 |
含有精神药物或gaba激动剂和有机酸的缀合物以及它们在治疗疼痛和其它cns疾病中的用途
|
TW200817413A
(en)
*
|
2006-07-20 |
2008-04-16 |
Genelabs Tech Inc |
Polycyclic viral inhibitors
|
KR20090027734A
(ko)
*
|
2006-07-27 |
2009-03-17 |
(주)아모레퍼시픽 |
난용성 약물의 나노입자를 포함하는 분말의 제조방법
|
WO2008022281A1
(en)
|
2006-08-16 |
2008-02-21 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Small molecule inhibitors of kynurenine-3-monooxygenase
|
WO2008022286A2
(en)
|
2006-08-16 |
2008-02-21 |
The J. David Gladstone Institutes, A Testamentary Trust Established Under The Will Of J. David Gladstone |
Small molecule inhibitors of kynurenine-3-monooxygenase
|
EP2057151A4
(en)
*
|
2006-08-28 |
2010-07-21 |
Hetero Drugs Ltd |
PROCESS FOR PURIFYING APREPITANT
|
CL2007002567A1
(es)
|
2006-09-08 |
2008-02-01 |
Amgen Inc |
Proteinas aisladas de enlace a activina a humana.
|
WO2008030557A2
(en)
*
|
2006-09-08 |
2008-03-13 |
Johns Hopkins University |
Compositions and methods for enhancing transport through mucus
|
US8080645B2
(en)
|
2007-10-01 |
2011-12-20 |
Longhorn Vaccines & Diagnostics Llc |
Biological specimen collection/transport compositions and methods
|
US8414926B1
(en)
|
2006-09-12 |
2013-04-09 |
University Of South Florida |
Nanoparticles with covalently bound surfactant for drug delivery
|
US8097419B2
(en)
|
2006-09-12 |
2012-01-17 |
Longhorn Vaccines & Diagnostics Llc |
Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009
|
US9481912B2
(en)
|
2006-09-12 |
2016-11-01 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and identifying nucleic acid sequences in biological samples
|
WO2008032327A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Organic nanoparticles obtained from microemulsions by solvent evaporation
|
AR063704A1
(es)
*
|
2006-09-14 |
2009-02-11 |
Makhteshim Chem Works Ltd |
Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones
|
CL2007002689A1
(es)
|
2006-09-18 |
2008-04-18 |
Vitae Pharmaceuticals Inc |
Compuestos derivados de piperidin-1-carboxamida, inhibidores de la renina; compuestos intermediarios; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como hipertension, insuficiencia cardiaca, fibrosis cardiaca, entre otras.
|
KR20090080046A
(ko)
*
|
2006-09-22 |
2009-07-23 |
라보팜 인코포레이트 |
pH 표적화된 약물 운반용 조성물 및 방법
|
EP2431483B1
(en)
|
2006-10-20 |
2015-04-01 |
Celera Corporation |
Genetic polymorphisms associated with venous thrombosis, methods of detection and uses thereof
|
CN1946120B
(zh)
*
|
2006-10-20 |
2010-05-12 |
华为技术有限公司 |
实现话单关联的方法及系统
|
US8946200B2
(en)
*
|
2006-11-02 |
2015-02-03 |
Southwest Research Institute |
Pharmaceutically active nanosuspensions
|
WO2008133722A2
(en)
*
|
2006-11-10 |
2008-11-06 |
Ucb Pharma S.A. |
Anti human sclerostin antibodies
|
US20100036091A1
(en)
*
|
2006-11-10 |
2010-02-11 |
Amgen Inc. |
Antibody-based diagnostics and therapeutics
|
CA2669392C
(en)
*
|
2006-11-17 |
2016-05-10 |
Abbott Gmbh & Co. Kg |
Nanocrystals for use in topical cosmetic formulations and method of production thereof
|
KR20080047959A
(ko)
*
|
2006-11-27 |
2008-05-30 |
주식회사 엠디바이오알파 |
비만, 당뇨, 대사성 질환, 퇴행성 질환 및 미토콘드리아이상 질환의 치료 또는 예방을 위한 나프토퀴논계 약제조성물
|
AU2007325628A1
(en)
|
2006-11-28 |
2008-06-05 |
Marinus Pharmaceuticals |
Nanoparticulate formulations and methods for the making and use thereof
|
US20080292695A1
(en)
*
|
2006-12-01 |
2008-11-27 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
US20090028935A1
(en)
*
|
2006-12-01 |
2009-01-29 |
Kristin Arnold |
Carvedilol forms, compositions, and methods of preparation thereof
|
US20080138405A1
(en)
*
|
2006-12-06 |
2008-06-12 |
Raheja Praveen |
Sirolimus nanodispersion
|
UA99270C2
(en)
|
2006-12-12 |
2012-08-10 |
Лексикон Фармасьютикалз, Инк. |
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
|
EP2104489A2
(en)
*
|
2006-12-26 |
2009-09-30 |
FemmePharma Holding Company, Inc. |
Topical administration of danazol
|
DE102007001473A1
(de)
|
2007-01-08 |
2008-07-10 |
Andreas Lemke |
Verfahren zur Herstellung und Anwendung von Mikro- und/oder Nanosuspensionen durch aufbauende Mikronisierung in Gegenwart von Trockeneis und hohem Druck
|
CN101605533B
(zh)
*
|
2007-02-09 |
2012-04-18 |
阿斯利康(瑞典)有限公司 |
制备固体非晶亚微米颗粒在水性介质中的稳定分散体的方法
|
TW200848039A
(en)
*
|
2007-02-09 |
2008-12-16 |
Astrazeneca Ab |
Pharmaceutical compositions
|
WO2008097664A1
(en)
|
2007-02-11 |
2008-08-14 |
Map Pharmaceuticals, Inc. |
Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
|
US20100151035A1
(en)
*
|
2007-03-13 |
2010-06-17 |
Sandoz Ag |
Pharmaceutical compositions of poorly soluble drugs
|
GEP20135925B
(en)
|
2007-03-14 |
2013-10-10 |
Exelixis Patent Co Llc |
Inhibitors of hedgehog pathway
|
TWI494133B
(zh)
|
2007-03-14 |
2015-08-01 |
Tibotec Pharm Ltd |
重組用粉末
|
CA2683409A1
(en)
*
|
2007-04-04 |
2008-10-16 |
Sigmoid Pharma Limited |
A pharmaceutical composition of tacrolimus
|
TWI405590B
(zh)
|
2007-04-06 |
2013-08-21 |
Activus Pharma Co Ltd |
微粉碎化有機化合物粒子之製法
|
DK2191001T3
(en)
|
2007-04-09 |
2016-09-19 |
Univ Florida |
RAAV VECTOR COMPOSITIONS WITH TYROSIN MODIFIED CAPSIDE PROTEINS AND PROCEDURES FOR USE THEREOF
|
ES2963291T3
(es)
|
2007-04-26 |
2024-03-26 |
Sublimity Therapeutics Ltd |
Fabricación de múltiples minicápsulas
|
EP2073798A2
(en)
*
|
2007-05-01 |
2009-07-01 |
Sigmoid Pharma Limited |
Pharmaceutical nimodipine compositions
|
US8703204B2
(en)
|
2007-05-03 |
2014-04-22 |
Bend Research, Inc. |
Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and anon-ionizable polymer
|
WO2008135828A2
(en)
|
2007-05-03 |
2008-11-13 |
Pfizer Products Inc. |
Nanoparticles comprising a drug, ethylcellulose, and a bile salt
|
CA2723470C
(en)
*
|
2007-05-07 |
2013-12-03 |
Hale Biopharma Ventures, Llc |
Nasal administration of benzodiazepines
|
US8530463B2
(en)
*
|
2007-05-07 |
2013-09-10 |
Hale Biopharma Ventures Llc |
Multimodal particulate formulations
|
WO2008144062A1
(en)
|
2007-05-21 |
2008-11-27 |
Novartis Ag |
Csf-1r inhibitors, compositions, and methods of use
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
JP5596540B2
(ja)
*
|
2007-05-31 |
2014-09-24 |
ジ アドミニストレイターズ オブ ザ チューレン エデュケイショナル ファンド |
安定な機能性ナノ粒子を形成する方法
|
EP2162120B1
(en)
|
2007-06-04 |
2016-05-04 |
Bend Research, Inc |
Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
|
US9545384B2
(en)
|
2007-06-04 |
2017-01-17 |
Bend Research, Inc. |
Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glocol succinate
|
ES2725450T3
(es)
|
2007-07-02 |
2019-09-24 |
Etubics Corp |
Métodos y composiciones para la producción de un vector adenoviral para su uso en vacunaciones múltiples
|
JP4419157B2
(ja)
|
2007-07-06 |
2010-02-24 |
エム・テクニック株式会社 |
生体摂取物微粒子の製造方法
|
US8426434B2
(en)
|
2007-07-12 |
2013-04-23 |
Tibotec Pharmaceuticals Ltd. |
Crystalline form of 4-[[4-[[4-(2-Cyanoethenyl)-2,6-dimethylphenyl]-amino]-2-pyrimidinyl]amino]benzonitrile
|
ATE554751T1
(de)
|
2007-07-13 |
2012-05-15 |
Bend Res Inc |
Nanopartikel mit einem nicht ionisierbaren polymer und einem anionischen zellulosepolymer
|
WO2009023179A2
(en)
*
|
2007-08-10 |
2009-02-19 |
Genelabs Technologies, Inc. |
Nitrogen containing bicyclic chemical entities for treating viral infections
|
US11041215B2
(en)
|
2007-08-24 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
PCR ready compositions and methods for detecting and identifying nucleic acid sequences
|
US9683256B2
(en)
|
2007-10-01 |
2017-06-20 |
Longhorn Vaccines And Diagnostics, Llc |
Biological specimen collection and transport system
|
EP3058954B1
(en)
|
2007-08-27 |
2017-03-01 |
Longhorn Vaccines and Diagnostics, LLC |
Immunogenic compositions and methods
|
US10004799B2
(en)
|
2007-08-27 |
2018-06-26 |
Longhorn Vaccines And Diagnostics, Llc |
Composite antigenic sequences and vaccines
|
WO2009029729A1
(en)
*
|
2007-08-31 |
2009-03-05 |
Genelabs Technologies, Inc. |
Amino tricyclic-nucleoside compounds, compositions, and methods of use
|
KR101545874B1
(ko)
*
|
2007-09-03 |
2015-08-20 |
나노테라퓨틱스, 인코포레이티드 |
난용성 약물의 전달을 위한 입상 조성물
|
US20090130210A1
(en)
*
|
2007-09-11 |
2009-05-21 |
Raheja Praveen |
Pharmaceutical compositions of sirolimus
|
US20090068266A1
(en)
*
|
2007-09-11 |
2009-03-12 |
Raheja Praveen |
Sirolimus having specific particle size and pharmaceutical compositions thereof
|
WO2009035558A1
(en)
*
|
2007-09-12 |
2009-03-19 |
Merck & Co., Inc. |
Process for the production of a crystalline glucagon receptor antagonist compound
|
CL2008002775A1
(es)
|
2007-09-17 |
2008-11-07 |
Amgen Inc |
Uso de un agente de unión a esclerostina para inhibir la resorción ósea.
|
EP2200588B1
(en)
*
|
2007-09-25 |
2019-03-20 |
Solubest Ltd. |
Compositions comprising lipophilic active compounds and method for their preparation
|
EP2535428B1
(en)
|
2007-10-01 |
2015-09-09 |
Longhorn Vaccines and Diagnostics, LLC |
Biological specimen collection and transport system and methods of use
|
US11041216B2
(en)
|
2007-10-01 |
2021-06-22 |
Longhorn Vaccines And Diagnostics, Llc |
Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples
|
WO2009048251A2
(en)
*
|
2007-10-11 |
2009-04-16 |
Mazence Inc. |
Pharmaceutical composition containing micronized particles of naphthoquinone-based compound
|
WO2009049304A1
(en)
*
|
2007-10-12 |
2009-04-16 |
Map Pharmaceuticals, Inc. |
Inhalation drug delivery
|
US9206233B2
(en)
*
|
2007-10-19 |
2015-12-08 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Templates for controlling synthesis of nanoparticles into discrete assemblies
|
US8785396B2
(en)
|
2007-10-24 |
2014-07-22 |
Mannkind Corporation |
Method and composition for treating migraines
|
US8642062B2
(en)
|
2007-10-31 |
2014-02-04 |
Abbott Cardiovascular Systems Inc. |
Implantable device having a slow dissolving polymer
|
US8039212B2
(en)
|
2007-11-05 |
2011-10-18 |
Celera Corporation |
Genetic polymorphisms associated with liver fibrosis, methods of detection and uses thereof
|
JP2011503232A
(ja)
*
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
US8598165B2
(en)
|
2007-11-26 |
2013-12-03 |
University Of Kansas |
Morpholines as selective inhibitors of cytochrome P450 2A13
|
JP5745855B2
(ja)
|
2007-11-28 |
2015-07-08 |
セコイア、ファーマシューティカルズ、インコーポレイテッドSequoia Pharmaceuticals,Inc. |
シトクロムp450 2d6を阻害するための組成物および方法
|
EP2231169B1
(en)
|
2007-12-06 |
2016-05-04 |
Bend Research, Inc. |
Pharmaceutical compositions comprising nanoparticles and a resuspending material
|
EP2240162A4
(en)
|
2007-12-06 |
2013-10-09 |
Bend Res Inc |
NANOTE PARTICLES WITH A NON-IONIZABLE POLYMER AND AN AMIN-FUNCTIONALIZED METHACRYLATE COPOLYMER
|
KR100961880B1
(ko)
*
|
2007-12-12 |
2010-06-09 |
중앙대학교 산학협력단 |
밀링에 의한 기능성 약물나노입자의 제조방법 및 상기제조방법에 의해 입자 표면이 개질된 약물나노입자 제제
|
US20090238867A1
(en)
*
|
2007-12-13 |
2009-09-24 |
Scott Jenkins |
Nanoparticulate Anidulafungin Compositions and Methods for Making the Same
|
CA2707400A1
(en)
*
|
2007-12-14 |
2009-06-25 |
Amgen Inc. |
Method for treating bone fracture with anti-sclerostin antibodies
|
UY31545A1
(es)
|
2007-12-20 |
2009-08-03 |
|
Nuevos derivados de 2-carboxamida cianoaminourea, sus sales y profarmacos farmacéuticamente aceptables, procesos de preparacion y aplicaciones
|
US20100054981A1
(en)
*
|
2007-12-21 |
2010-03-04 |
Board Of Regents, The University Of Texas System |
Magnetic nanoparticles, bulk nanocomposite magnets, and production thereof
|
US9242295B2
(en)
|
2007-12-21 |
2016-01-26 |
The Univeristy Of Texas At Arlington |
Bulk nanocomposite magnets and methods of making bulk nanocomposite magnets
|
WO2009086139A1
(en)
*
|
2007-12-21 |
2009-07-09 |
Genelabs Technologies, Inc. |
Condensed pentacyclic derivatives for use in the treatment of flaviviridae infections
|
KR101405823B1
(ko)
*
|
2007-12-24 |
2014-06-12 |
주식회사 케이티앤지생명과학 |
녹내장의 치료 및 예방을 위한 약제 조성물
|
KR20090071829A
(ko)
*
|
2007-12-28 |
2009-07-02 |
주식회사 머젠스 |
신장질환의 치료 및 예방을 위한 약제 조성물
|
CN101951957A
(zh)
*
|
2008-01-04 |
2011-01-19 |
百达尔公司 |
胰岛素释放作为组织的葡萄糖水平的函数的胰岛素制剂
|
IL188647A0
(en)
*
|
2008-01-08 |
2008-11-03 |
Orina Gribova |
Adaptable structured drug and supplements administration system (for oral and/or transdermal applications)
|
US20090202649A1
(en)
*
|
2008-02-06 |
2009-08-13 |
Subhash Gore |
Fenofibrate formulations
|
US8207369B2
(en)
|
2008-02-11 |
2012-06-26 |
Ramot At Tel-Aviv University Ltd. |
Conjugates for treating neurodegenerative diseases and disorders
|
US20090221620A1
(en)
|
2008-02-20 |
2009-09-03 |
Celera Corporation |
Gentic polymorphisms associated with stroke, methods of detection and uses thereof
|
WO2009105776A1
(en)
|
2008-02-21 |
2009-08-27 |
Sequoia Pharmaceuticals, Inc. |
Diamide inhibitors of cytochrome p450
|
EP2254555A4
(en)
*
|
2008-02-27 |
2013-10-09 |
Reddys Lab Ltd Dr |
APREPITANT FORMS WITH INCREASED SOLUBILITY AND PHARMACEUTICAL COMPOSITIONS FROM THEREOF
|
EP2259798B1
(en)
|
2008-03-05 |
2013-12-11 |
Baxter International Inc. |
Surface-modified particles and methods for targeted drug delivery
|
US8404850B2
(en)
*
|
2008-03-13 |
2013-03-26 |
Southwest Research Institute |
Bis-quaternary pyridinium-aldoxime salts and treatment of exposure to cholinesterase inhibitors
|
WO2009117401A2
(en)
*
|
2008-03-21 |
2009-09-24 |
Elan Pharama International Limited |
Compositions for site-specific delivery of imatinib and methods of use
|
CA2756690C
(en)
|
2008-03-28 |
2016-08-16 |
Hale Biopharma Ventures, Llc |
Administration of benzodiazepine compositions
|
HU230862B1
(hu)
*
|
2008-04-28 |
2018-10-29 |
DARHOLDING Vagyonkezelő Kft |
Berendezés és eljárás nanorészecskék folyamatos üzemű előállítására
|
US20110064816A1
(en)
*
|
2008-05-13 |
2011-03-17 |
Dr. Reddy's Laboratories Ltd. |
Atorvastatin compositions
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
US20090311335A1
(en)
*
|
2008-06-12 |
2009-12-17 |
Scott Jenkins |
Combination of a triptan and an nsaid
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
RU2608439C2
(ru)
|
2008-06-13 |
2017-01-18 |
Маннкайнд Корпорейшн |
Ингалятор для сухого порошка и система для доставки лекарственных средств
|
GB2462022B
(en)
|
2008-06-16 |
2011-05-25 |
Biovascular Inc |
Controlled release compositions of agents that reduce circulating levels of platelets and methods thereof
|
JP5479465B2
(ja)
|
2008-06-20 |
2014-04-23 |
マンカインド コーポレイション |
吸入努力をリアルタイムにプロファイルする対話式機器および方法
|
US8216786B2
(en)
|
2008-07-09 |
2012-07-10 |
Celera Corporation |
Genetic polymorphisms associated with cardiovascular diseases, methods of detection and uses thereof
|
US20100151037A1
(en)
*
|
2008-08-07 |
2010-06-17 |
Yivan Jiang |
Method for the preparation of nanoparticles containing a poorly water-soluble pharmaceutically active compound
|
DE102008037025C5
(de)
|
2008-08-08 |
2016-07-07 |
Jesalis Pharma Gmbh |
Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
US8722706B2
(en)
*
|
2008-08-15 |
2014-05-13 |
Southwest Research Institute |
Two phase bioactive formulations of bis-quaternary pyridinium oxime sulfonate salts
|
RU2554347C2
(ru)
|
2008-08-19 |
2015-06-27 |
Ксенопорт, Инк. |
Пролекарства метилгидрофумарата, фармацевтические композиции с ними и способы применения
|
US9700525B2
(en)
|
2008-08-20 |
2017-07-11 |
Board Of Supervisors Of Louisiana State University And Agricultural & Mechanical College |
Continuous local slow-release of therapeutics for head and neck problems and upper aerodigestive disorders
|
EP2373346B1
(en)
|
2008-09-10 |
2019-06-12 |
BioChemics, Inc. |
Ibuprofen for topical administration
|
CA2737543C
(en)
*
|
2008-09-19 |
2015-01-06 |
Activus Pharma Co., Ltd. |
Composite organic compound powder for medical use and production method and suspension of the same
|
TWI580441B
(zh)
*
|
2008-09-19 |
2017-05-01 |
愛爾康研究有限公司 |
穩定的藥學次微米懸浮液及其形成方法
|
GB0818403D0
(en)
*
|
2008-10-08 |
2008-11-12 |
Univ Leuven Kath |
Aqueous electrophoretic deposition
|
US8309134B2
(en)
*
|
2008-10-03 |
2012-11-13 |
Southwest Research Institute |
Modified calcium phosphate nanoparticle formation
|
EP2334845A2
(en)
*
|
2008-10-06 |
2011-06-22 |
Katholieke Universiteit Leuven K.U. Leuven R&D |
Functional layers of biomolecules and living cells, and a novel system to produce such
|
US20100098770A1
(en)
*
|
2008-10-16 |
2010-04-22 |
Manikandan Ramalingam |
Sirolimus pharmaceutical formulations
|
US8277697B2
(en)
*
|
2008-10-29 |
2012-10-02 |
Global Oled Technology Llc |
Color filter element with improved colorant dispersion
|
EP2370438A1
(en)
|
2008-12-04 |
2011-10-05 |
Exelixis, Inc. |
Imidazo [1,2a]pyridine derivatives, their use as s1p1 agonists and methods for their production
|
WO2010075065A2
(en)
|
2008-12-15 |
2010-07-01 |
Banner Pharmacaps, Inc. |
Methods for enhancing the release and absorption of water insoluble active agents
|
CA2746307C
(en)
|
2008-12-17 |
2013-11-19 |
Amgen Inc. |
Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
|
BRPI0922508A8
(pt)
|
2008-12-23 |
2016-01-19 |
Pharmasset Inc |
Análogos de nucleosídeo
|
SG172359A1
(en)
|
2008-12-23 |
2011-07-28 |
Pharmasset Inc |
Nucleoside phosphoramidates
|
KR20110104074A
(ko)
|
2008-12-23 |
2011-09-21 |
파마셋 인코포레이티드 |
퓨린 뉴클레오시드의 합성
|
US20100159010A1
(en)
*
|
2008-12-24 |
2010-06-24 |
Mutual Pharmaceutical Company, Inc. |
Active Agent Formulations, Methods of Making, and Methods of Use
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
MX2011007172A
(es)
|
2009-01-02 |
2011-08-04 |
Fournier Lab Ireland Ltd |
Uso novedoso de fibratos.
|
CA2782655A1
(en)
|
2009-01-06 |
2010-07-15 |
Pharmanova, Inc. |
Nanoparticle pharmaceutical formulations
|
US11304960B2
(en)
|
2009-01-08 |
2022-04-19 |
Chandrashekar Giliyar |
Steroidal compositions
|
US20100183687A1
(en)
*
|
2009-01-22 |
2010-07-22 |
Cox D Phillip |
Process for preparing particles of opioids and compositions produced thereby
|
AR075180A1
(es)
*
|
2009-01-29 |
2011-03-16 |
Novartis Ag |
Formulaciones orales solidas de una pirido-pirimidinona
|
WO2010087447A1
(ja)
|
2009-01-30 |
2010-08-05 |
明治製菓株式会社 |
微粉砕医薬組成物
|
WO2010091104A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Glucosylceramide synthase inhibitors
|
WO2010091164A1
(en)
|
2009-02-06 |
2010-08-12 |
Exelixis, Inc. |
Inhibitors of glucosylceramide synthase
|
WO2010091198A1
(en)
|
2009-02-06 |
2010-08-12 |
University Of Southern California |
Therapeutic compositions comprising monoterpenes
|
US20100204265A1
(en)
*
|
2009-02-09 |
2010-08-12 |
Genelabs Technologies, Inc. |
Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
|
AU2010216239B2
(en)
|
2009-02-18 |
2012-06-14 |
Amgen Inc. |
Indole/benzimidazole compounds as mTOR kinase inhibitors
|
LT2400950T
(lt)
|
2009-02-26 |
2019-08-26 |
Glaxo Group Limited |
Farmacinės kompozicijos, apimančios 4-{(1 r)-2-[(6-{2-[(2,6-dichlorbenzil)oksi]etoksi}heksil)amino]-1-hidroksetil}-2-(hidroksimetil)fenolį
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
WO2010105094A1
(en)
|
2009-03-11 |
2010-09-16 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
WO2010110931A2
(en)
|
2009-03-23 |
2010-09-30 |
The Brigham And Women's Hospital, Inc. |
Glycoconjugate vaccines
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
WO2010114770A1
(en)
*
|
2009-03-30 |
2010-10-07 |
Cerulean Pharma Inc. |
Polymer-agent conjugates, particles, compositions, and related methods of use
|
US20100249071A1
(en)
|
2009-03-30 |
2010-09-30 |
Exelixis, Inc. |
Modulators of S1P and Methods of Making And Using
|
WO2010118232A1
(en)
*
|
2009-04-09 |
2010-10-14 |
Elan Pharma International Limited |
Controlled-release clozapine compositions
|
US20100268187A1
(en)
*
|
2009-04-17 |
2010-10-21 |
Ranbaxy Laboratories Limited |
Packaging for sirolimus and composition thereof
|
CN102438594A
(zh)
|
2009-04-24 |
2012-05-02 |
伊休蒂卡有限公司 |
吲哚美辛的新剂型
|
MY168079A
(en)
|
2009-04-24 |
2018-10-11 |
Iceutica Pty Ltd |
A novel formulation of diclofenac
|
US10952965B2
(en)
*
|
2009-05-15 |
2021-03-23 |
Baxter International Inc. |
Compositions and methods for drug delivery
|
US20100291221A1
(en)
*
|
2009-05-15 |
2010-11-18 |
Robert Owen Cook |
Method of administering dose-sparing amounts of formoterol fumarate-budesonide combination particles by inhalation
|
EP2253306A1
(en)
|
2009-05-18 |
2010-11-24 |
Royal College of Surgeons in Ireland |
Orodispersible dosage forms containing solid drug dispersions
|
SG176145A1
(en)
|
2009-05-18 |
2011-12-29 |
Sigmoid Pharma Ltd |
Composition comprising oil drops
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
WO2010135568A1
(en)
|
2009-05-22 |
2010-11-25 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of mtor and their use to treat cancer
|
WO2010135714A2
(en)
|
2009-05-22 |
2010-11-25 |
The Methodist Hospital Research Institute |
Methods for modulating adipocyte expression using microrna compositions
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
EP2435027B1
(en)
|
2009-05-27 |
2016-10-05 |
Alkermes Pharma Ireland Limited |
Reduction of flake-like aggregation in nanoparticulate meloxicam compositions
|
TR200904500A2
(tr)
|
2009-06-10 |
2009-10-21 |
Öner Levent |
Ezetimib nanokristallerinin hazırlanması için yöntem ve farmasötik formülasyonları.
|
MX2011013260A
(es)
|
2009-06-12 |
2012-02-28 |
Adagio Pharmaceuticals Ltd |
Apomorfina sublingual.
|
KR20180036807A
(ko)
|
2009-06-12 |
2018-04-09 |
맨카인드 코포레이션 |
한정된 비표면적을 갖는 디케토피페라진 마이크로입자
|
JP5775071B2
(ja)
|
2009-06-16 |
2015-09-09 |
ファイザー・インク |
アピキサバンの製剤形
|
US9149024B2
(en)
|
2009-06-22 |
2015-10-06 |
Massachusetts Eye & Ear Infirmary |
Islet1 (Isl1) and hearing loss
|
US8293753B2
(en)
|
2009-07-02 |
2012-10-23 |
Novartis Ag |
Substituted 2-carboxamide cycloamino ureas
|
US20110003000A1
(en)
*
|
2009-07-06 |
2011-01-06 |
Femmepharma Holding Company, Inc. |
Transvaginal Delivery of Drugs
|
EP2451442A4
(en)
|
2009-07-09 |
2014-02-12 |
Oshadi Drug Administration Ltd |
MATRIX COMPOSITION COMPOSITIONS, METHODS AND USES
|
US20130029970A1
(en)
|
2009-07-10 |
2013-01-31 |
Ironwood Pharmaceuticals, Inc |
CB Receptor Agonists
|
EP2283824B1
(en)
|
2009-07-30 |
2017-04-19 |
Special Products Line S.p.A. |
Compositions and formulations based on swellable matrices for sustained release of poorly soluble drugs such as clarithromycin
|
AR077692A1
(es)
|
2009-08-06 |
2011-09-14 |
Vitae Pharmaceuticals Inc |
Sales de 2-((r)-(3-clorofenil) ((r)-1-((s) -2-(metilamino)-3-((r)-tetrahidro-2h-piran-3-il) propilcarbamoil) piperidin -3-il) metoxi) etilcarbamato de metilo
|
UA108618C2
(uk)
|
2009-08-07 |
2015-05-25 |
|
Застосування c-met-модуляторів в комбінації з темозоломідом та/або променевою терапією для лікування раку
|
US9878036B2
(en)
|
2009-08-12 |
2018-01-30 |
Sigmoid Pharma Limited |
Immunomodulatory compositions comprising a polymer matrix and an oil phase
|
EP2298296A1
(en)
|
2009-08-25 |
2011-03-23 |
CNRS Centre National De La Recherche Scientifique |
Composition and method for treating cognitive impairments in down syndrome subjects
|
ES2545794T3
(es)
|
2009-08-28 |
2015-09-15 |
Research Development Foundation |
Análogos de urocortina 2 y usos de los mismos
|
US9775819B2
(en)
*
|
2009-09-16 |
2017-10-03 |
R.P. Scherer Technologies, Llc |
Oral solid dosage form containing nanoparticles and process of formulating the same using fish gelatin
|
UY32919A
(es)
|
2009-10-02 |
2011-04-29 |
Boehringer Ingelheim Int |
Composición farmacéutica, forma de dosificación farmacéutica, procedimiento para su preparación, mé todos para su tratamiento y sus usos
|
CN106361696B
(zh)
*
|
2009-10-16 |
2020-10-23 |
莱富凯尔创新私人有限公司 |
用于治疗真菌感染的含胆固醇的脂质体两性霉素的制剂
|
WO2011049629A2
(en)
|
2009-10-22 |
2011-04-28 |
Api Genesis, Llc |
Methods of making and using compositions comprising flavonoids
|
US9016147B2
(en)
|
2009-11-03 |
2015-04-28 |
Mannkind Corporation |
Apparatus and method for simulating inhalation efforts
|
JP2013510092A
(ja)
|
2009-11-05 |
2013-03-21 |
レクシコン ファーマシューティカルズ インコーポレイテッド |
がんの治療のためのトリプトファンヒドロキシラーゼ阻害剤
|
CA2780292A1
(en)
*
|
2009-11-10 |
2011-05-19 |
Celgene Corporation |
Nanosus pens ion of a poorly soluble drug made by microfluidization process
|
GB0921075D0
(en)
|
2009-12-01 |
2010-01-13 |
Glaxo Group Ltd |
Novel combination of the therapeutic agents
|
MX2012006231A
(es)
|
2009-12-03 |
2012-07-03 |
Alcon Res Ltd |
Suspension de nanoparticulas que contienen polimero de carboxivinilo.
|
AU2010329440A1
(en)
*
|
2009-12-09 |
2012-08-09 |
Bar-Ilan University |
Methods of improving cognitive functions
|
TW201120027A
(en)
|
2009-12-11 |
2011-06-16 |
Exelixis Inc |
TGR5 agonists
|
JP2013514992A
(ja)
|
2009-12-18 |
2013-05-02 |
アムジェン インコーポレイテッド |
Wise結合剤およびエピトープ
|
WO2011076208A2
(en)
|
2009-12-22 |
2011-06-30 |
Leo Pharma A/S |
Calcipotriol monohydrate nanocrystals
|
UY33110A
(es)
|
2009-12-23 |
2011-07-29 |
Ironwood Pharmaceuticals Inc |
Moduladores de CRTH2
|
SG182573A1
(en)
|
2010-01-27 |
2012-08-30 |
Glaxosmithkline Biolog Sa |
Modified tuberculosis antigens
|
US9028873B2
(en)
*
|
2010-02-08 |
2015-05-12 |
Southwest Research Institute |
Nanoparticles for drug delivery to the central nervous system
|
WO2011100319A1
(en)
|
2010-02-09 |
2011-08-18 |
Exelixis, Inc. |
Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k and mtor in combination with autophagy inhibitors
|
WO2011100359A1
(en)
|
2010-02-09 |
2011-08-18 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid agonists
|
US20130196960A1
(en)
|
2010-02-09 |
2013-08-01 |
Ironwood Pharmaceuticals, Inc. |
Cannabinoid Receptor Agonists
|
US20130137635A1
(en)
|
2010-02-10 |
2013-05-30 |
Lexicon Pharmaceuticals, Inc. |
Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
|
MX2012009561A
(es)
|
2010-02-17 |
2012-11-23 |
Amgen Inc |
Carboxamidas como inhibidores de canales de sodio dependientes del voltaje.
|
US8440651B2
(en)
|
2010-02-22 |
2013-05-14 |
F. Hoffmann-La Roche Ag |
Pyrido[3,2-d]pyrimidine PI3K delta inhibitor compounds and methods of use
|
WO2011104637A2
(en)
*
|
2010-02-24 |
2011-09-01 |
Ramot At Tel-Aviv University Ltd. |
Crystalline forms of the tri-mesylate salt of perphenazine-gaba and process of producing the same
|
JP5677409B2
(ja)
*
|
2010-03-11 |
2015-02-25 |
浜松ホトニクス株式会社 |
微粒子分散液製造方法および微粒子分散液製造装置
|
US8828445B2
(en)
|
2010-03-22 |
2014-09-09 |
Bio-Synectics Inc. |
Method for preparing nano-particles utilizing a saccharide anti-coagulant
|
EP3290428B1
(en)
|
2010-03-31 |
2021-10-13 |
Gilead Pharmasset LLC |
Tablet comprising crystalline (s)-isopropyl 2-(((s)-(((2r,3r,4r,5r)-5-(2,4-dioxo-3,4-dihydropyrimidin-1 (2h)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate
|
PT2752422T
(pt)
|
2010-03-31 |
2017-11-07 |
Gilead Pharmasset Llc |
Síntese estereosseletiva de princípios ativos contendo fósforo
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
DE102010003711B4
(de)
*
|
2010-04-08 |
2015-04-09 |
Jesalis Pharma Gmbh |
Verfahren zur Herstellung kristalliner Wirkstoffpartikel
|
US20110269735A1
(en)
|
2010-04-19 |
2011-11-03 |
Celera Corporation |
Genetic polymorphisms associated with statin response and cardiovascular diseases, methods of detection and uses thereof
|
ES2911185T3
(es)
|
2010-04-23 |
2022-05-18 |
Univ Florida |
Composiciones de rAAV-guanilato ciclasa y métodos para tratar la amaurosis congénita de Leber 1 (LCA1)
|
WO2011135580A2
(en)
|
2010-04-28 |
2011-11-03 |
Cadila Healthcare Limited |
Pharmaceutical compositions of sirolimus
|
US20130116333A1
(en)
*
|
2010-05-05 |
2013-05-09 |
Ratiopharm Gmbh |
Solid tapentadol in non-crystalline form
|
US8362007B1
(en)
|
2010-05-11 |
2013-01-29 |
Demerx, Inc. |
Substituted noribogaine
|
US9394294B2
(en)
|
2010-05-11 |
2016-07-19 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
US8765737B1
(en)
|
2010-05-11 |
2014-07-01 |
Demerx, Inc. |
Methods and compositions for preparing and purifying noribogaine
|
SG185515A1
(en)
|
2010-05-13 |
2012-12-28 |
Amgen Inc |
Nitrogen heterocyclic compounds useful as pde10 inhibitors
|
WO2011143495A1
(en)
|
2010-05-13 |
2011-11-17 |
Amgen Inc. |
Heteroaryloxyheterocyclyl compounds as pde10 inhibitors
|
US8946230B2
(en)
|
2010-05-13 |
2015-02-03 |
Amgen Inc. |
Aryl- and heteroaryl- nitrogen-heterocyclic compounds as PDE10 inhibitors
|
AU2011253058A1
(en)
|
2010-05-13 |
2012-12-06 |
Amgen Inc. |
Heteroaryloxycarbocyclyl compounds as PDE10 inhibitors
|
ES2773031T3
(es)
|
2010-05-14 |
2020-07-09 |
Amgen Inc |
Formulaciones de anticuerpos anti-esclerostina a alta concentración
|
US9012511B2
(en)
|
2010-05-19 |
2015-04-21 |
Alkermes Pharma Ireland Limited |
Nanoparticulate cinacalcet compositions
|
HUP1000325A2
(en)
|
2010-06-18 |
2012-01-30 |
Druggability Technologies Ip Holdco Jersey Ltd |
Nanostructured aprepitant compositions and process for their preparation
|
RU2531455C2
(ru)
|
2010-06-21 |
2014-10-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
US9586954B2
(en)
|
2010-06-22 |
2017-03-07 |
Demerx, Inc. |
N-substituted noribogaine prodrugs
|
US8802832B2
(en)
|
2010-06-22 |
2014-08-12 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
US8741891B1
(en)
|
2010-06-22 |
2014-06-03 |
Demerx, Inc. |
N-substituted noribogaine prodrugs
|
US8637648B1
(en)
|
2010-06-22 |
2014-01-28 |
Demerx, Inc. |
Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
|
EP3263111A1
(en)
|
2010-06-30 |
2018-01-03 |
Victoria Link Ltd |
Methods and compositions for treatment of multiple sclerosis
|
SG186889A1
(en)
|
2010-07-09 |
2013-02-28 |
Exelixis Inc |
Combinations of kinase inhibitors for the treatment of cancer
|
US20130216552A1
(en)
|
2010-07-12 |
2013-08-22 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
WO2012009134A1
(en)
|
2010-07-12 |
2012-01-19 |
Ironwood Pharmaceuticals, Inc. |
Crth2 modulators
|
CN103079571A
(zh)
|
2010-07-23 |
2013-05-01 |
德莫科斯公司 |
降伊波加因碱组合物
|
ES2705027T3
(es)
|
2010-08-19 |
2019-03-21 |
Buck Institute For Age Res |
Métodos de tratamiento del deterioro cognitivo leve (DCL) y trastornos relacionados
|
AU2011302124B2
(en)
|
2010-09-14 |
2016-03-17 |
Exelixis, Inc. |
Inhibitors of PI3K-delta and methods of their use and manufacture
|
ES2693257T3
(es)
|
2010-09-14 |
2018-12-10 |
Exelixis, Inc. |
Inhibidores de PI3K-delta y métodos para su uso y fabricación
|
JP2013537201A
(ja)
|
2010-09-14 |
2013-09-30 |
エグゼリクシス, インコーポレイテッド |
Jak1インヒビターとしてのフタラジン誘導体
|
WO2012038963A1
(en)
|
2010-09-22 |
2012-03-29 |
Ramot At Tel-Aviv University Ltd. |
An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
|
US9029369B2
(en)
|
2010-09-23 |
2015-05-12 |
Nuformix Limited |
Aprepitant L-proline composition and cocrystal
|
EA027476B1
(ru)
|
2010-09-27 |
2017-07-31 |
Экселиксис, Инк. |
Применение n-(4-{[6,7-бис-(метилокси)хинолин-4-ил]окси}фенил)-n'-(4-фторфенил)циклопропан-1,1-дикарбоксамида для лечения кастрационно-резистентного рака простаты и остеобластических метастазов в кости
|
WO2012044574A1
(en)
|
2010-09-27 |
2012-04-05 |
Exelixis, Inc. |
Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
|
WO2012044577A1
(en)
|
2010-09-27 |
2012-04-05 |
Exelixis, Inc. |
Dual inhibitors of met and vegf for the treatment of castration resistant prostate cancer and osteoblastic bone metastases
|
JP2014504260A
(ja)
*
|
2010-10-15 |
2014-02-20 |
グラクソ グループ リミテッド |
集合ナノ粒子状薬物製剤、その製造及び使用
|
CA2816123A1
(en)
*
|
2010-11-02 |
2012-05-10 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for the delivery of therapeutics
|
WO2012061337A1
(en)
|
2010-11-02 |
2012-05-10 |
Exelixis, Inc. |
Fgfr2 modulators
|
US20120108651A1
(en)
|
2010-11-02 |
2012-05-03 |
Leiden University Medical Center (LUMC) Acting on Behalf of Academic Hospital Leiden (AZL) |
Genetic polymorphisms associated with venous thrombosis and statin response, methods of detection and uses thereof
|
WO2012065019A2
(en)
|
2010-11-12 |
2012-05-18 |
Exelixis, Inc. |
Pyridopyrimidinone inhibitors of p13k alpha
|
WO2012065057A2
(en)
|
2010-11-12 |
2012-05-18 |
Exelixis, Inc. |
Phosphatidylinositol 3-kinase inhibitors and methods of their use
|
EP2640367A2
(en)
|
2010-11-15 |
2013-09-25 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
|
WO2012068096A2
(en)
|
2010-11-15 |
2012-05-24 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of pi3k/mtor and methods of their use and manufacture
|
WO2012071509A2
(en)
|
2010-11-24 |
2012-05-31 |
Exelixis, Inc. |
Benzoxazepines as inhibitors of p13k/mtor and methods of their use and manufacture
|
GB201020032D0
(en)
|
2010-11-25 |
2011-01-12 |
Sigmoid Pharma Ltd |
Composition
|
US9358241B2
(en)
|
2010-11-30 |
2016-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
US20180153904A1
(en)
|
2010-11-30 |
2018-06-07 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
PT3042910T
(pt)
|
2010-11-30 |
2019-04-16 |
Gilead Pharmasset Llc |
2'-espiro-nucleósidos para utilização na terapia da hepatite c
|
US9034858B2
(en)
|
2010-11-30 |
2015-05-19 |
Lipocine Inc. |
High-strength testosterone undecanoate compositions
|
AU2011338389A1
(en)
|
2010-12-09 |
2013-06-13 |
Amgen Inc. |
Bicyclic compounds as Pim inhibitors
|
US20120148675A1
(en)
|
2010-12-10 |
2012-06-14 |
Basawaraj Chickmath |
Testosterone undecanoate compositions
|
KR102025238B1
(ko)
|
2010-12-16 |
2019-09-25 |
선오비온 파마슈티컬스 인코포레이티드 |
설하 필름
|
US9351989B2
(en)
|
2010-12-29 |
2016-05-31 |
Inhibitex, Inc. |
Substituted purine nucleosides, phosphoroamidate and phosphorodiamidate derivatives for treatment of viral infections
|
JP2014505052A
(ja)
|
2011-01-06 |
2014-02-27 |
ベータ ファルマ カナダ インコーポレーテッド |
癌の治療および予防用の新規なウレア
|
EP2481740B1
(en)
|
2011-01-26 |
2015-11-04 |
DemeRx, Inc. |
Methods and compositions for preparing noribogaine from voacangine
|
CA2828000A1
(en)
|
2011-03-01 |
2012-09-07 |
Amgen Inc. |
Bispecific binding agents
|
JP2014510105A
(ja)
|
2011-03-22 |
2014-04-24 |
アムジエン・インコーポレーテツド |
Pim阻害剤としてのアゾール化合物
|
AP3981A
(en)
|
2011-03-25 |
2017-01-05 |
Amgen Inc |
Anti - sclerostin antibody crystals and formulations thereof
|
AU2012236150B2
(en)
|
2011-04-01 |
2016-03-31 |
Mannkind Corporation |
Blister package for pharmaceutical cartridges
|
CN108210469A
(zh)
|
2011-04-15 |
2018-06-29 |
詹森药业有限公司 |
冻干药物纳米混悬剂
|
EP2701722A4
(en)
|
2011-04-28 |
2014-12-31 |
Univ Southern California |
CANCEROUS MARKERS OF HUMAN SUPPRESSIVE MYELOID CELLS
|
KR20140040726A
(ko)
|
2011-04-29 |
2014-04-03 |
엑셀리시스, 인코포레이티드 |
PI3K/mTOR의 피리도피리미디논 억제제를 사용하는 림프종을 치료하는 방법
|
US9187486B2
(en)
|
2011-04-29 |
2015-11-17 |
Amgen Inc. |
Bicyclic pyridazine compounds as Pim inhibitors
|
WO2012154879A2
(en)
|
2011-05-09 |
2012-11-15 |
Van Andel Research Institute |
Autophagy inhibitors
|
EP2706940B1
(en)
|
2011-05-13 |
2016-12-14 |
Broncus Medical, Inc. |
Methods and devices for ablation of tissue
|
US8709034B2
(en)
|
2011-05-13 |
2014-04-29 |
Broncus Medical Inc. |
Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
|
US20140107151A1
(en)
|
2011-05-17 |
2014-04-17 |
Principia Biophama Inc. |
Tyrosine kinase inhibitors
|
US9376438B2
(en)
|
2011-05-17 |
2016-06-28 |
Principia Biopharma, Inc. |
Pyrazolopyrimidine derivatives as tyrosine kinase inhibitors
|
MX2013013331A
(es)
|
2011-05-17 |
2014-10-17 |
Principia Biopharma Inc |
Derivados de azaindol como inhibidores de tirosina-cinasas.
|
CA2836410C
(en)
|
2011-05-17 |
2019-08-20 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
PL3415139T3
(pl)
|
2011-06-14 |
2022-07-11 |
Neurelis, Inc. |
Podawanie benzodiazepiny
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
CN103608030A
(zh)
|
2011-06-21 |
2014-02-26 |
昂科发克特公司 |
用于治疗和诊断癌症的组合物和方法
|
CN103619839B
(zh)
|
2011-06-28 |
2016-06-01 |
福建省闽东力捷迅药业有限公司 |
抗-变态反应的苯并环庚并噻吩衍生物
|
WO2013012649A1
(en)
|
2011-07-15 |
2013-01-24 |
Glaxosmithkline Llc |
Azaindole compounds and methods for treating hiv
|
MX350269B
(es)
|
2011-07-22 |
2017-08-31 |
Chemocentryx Inc |
Una forma cristalina de la sal de sodio de 4-ter-butil-n-[4-cloro- 2-(1-oxi-piridina-4-carbonil)-fenil]-bencensulfonamida.
|
WO2013016156A1
(en)
|
2011-07-22 |
2013-01-31 |
Glaxo Group Limited |
Polymorphic forms of the sodium salt of 4-tert- butyl -n-[4-chloro-2-(1-oxy-pyridine-4-carbonyl)-phenyl]-benzene sulfonamide
|
AU2012290083B2
(en)
|
2011-08-04 |
2017-07-20 |
Amgen Inc. |
Method for treating bone gap defects
|
US9617274B1
(en)
|
2011-08-26 |
2017-04-11 |
Demerx, Inc. |
Synthetic noribogaine
|
PL2751094T3
(pl)
|
2011-09-01 |
2018-11-30 |
Glaxo Group Limited |
Nowa postać krystaliczna
|
UY34339A
(es)
|
2011-09-14 |
2013-04-30 |
Exelixis Inc |
Inhibidores de la fosfatidilinositol 3-quinasa para el tratamiento del cancer
|
KR101794032B1
(ko)
|
2011-09-21 |
2017-11-07 |
(주)바이오시네틱스 |
나노입자 제조방법
|
WO2013043553A1
(en)
|
2011-09-22 |
2013-03-28 |
Glaxosmithkline Llc |
Pyrrolopyridinone compounds and methods for treating hiv
|
WO2013043840A1
(en)
|
2011-09-22 |
2013-03-28 |
Exelixis, Inc. |
Method for treating osteoporosis
|
US9730884B2
(en)
*
|
2011-09-29 |
2017-08-15 |
Plx Opco Inc. |
pH dependent carriers for targeted release of pharmaceuticals along the gastrointestinal tract, compositions therefrom, and making and using same
|
WO2013056067A1
(en)
|
2011-10-13 |
2013-04-18 |
Exelixis, Inc. |
Compounds for use in the treatment of basal cell carcinoma
|
TWI580442B
(zh)
*
|
2011-10-19 |
2017-05-01 |
傑特大學 |
醫藥毫微懸浮物
|
JP6018640B2
(ja)
|
2011-10-24 |
2016-11-02 |
マンカインド コーポレイション |
疼痛を緩和するのに有効な鎮痛組成物並びに当該組成物を含む乾燥粉末及び乾燥粉末薬剤輸送システム
|
AU2012332486A1
(en)
|
2011-11-01 |
2014-06-19 |
Arthur Decillis |
N- (3- { [ (3- { [2-chloro-5- (methoxy) phenyl] amino} quinoxalin- 2 -yl) amino] sulfonyl} phe nyl) - 2 -methylalaninamide as phosphatidylinositol 3 - kinase inhibitor for the treatment of lymphoproliferative malignancies
|
WO2013067306A1
(en)
|
2011-11-02 |
2013-05-10 |
Exelixis, Inc. |
Phosphatidylinositol 3-kinase inhibitors for the treatment of childhood cancers
|
TW201818937A
(zh)
|
2011-11-08 |
2018-06-01 |
美商艾克塞里克斯公司 |
治療癌症之方法
|
AU2012335750A1
(en)
|
2011-11-08 |
2014-06-05 |
Exelixis, Inc. |
Method of quantifying cancer treatment
|
CN104080797A
(zh)
|
2011-11-11 |
2014-10-01 |
弗雷德哈钦森癌症研究中心 |
针对癌症的靶向细胞周期蛋白a1的t细胞免疫疗法
|
US9562015B2
(en)
|
2011-11-17 |
2017-02-07 |
The Regents Of The University Of Colorado, A Body |
Methods and compositions for enhanced drug delivery to the eye and extended delivery formulations
|
WO2013078235A1
(en)
|
2011-11-23 |
2013-05-30 |
Broncus Medical Inc |
Methods and devices for diagnosing, monitoring, or treating medical conditions through an opening through an airway wall
|
CN104159584A
(zh)
|
2011-11-25 |
2014-11-19 |
诺弗米克斯有限公司 |
阿瑞吡坦l-脯氨酸溶剂化物-组合物和共晶体
|
WO2013085922A1
(en)
|
2011-12-09 |
2013-06-13 |
Demerx, Inc. |
Phosphate esters of noribogaine
|
JO3387B1
(ar)
|
2011-12-16 |
2019-03-13 |
Glaxosmithkline Llc |
مشتقات بيتولين
|
SG11201403718YA
(en)
|
2011-12-28 |
2014-07-30 |
Amgen Inc |
Method of treating alveolar bone loss through the use of anti-sclerostin antibodies
|
US9150584B2
(en)
|
2012-01-25 |
2015-10-06 |
Demerx, Inc. |
Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
|
US8877921B2
(en)
|
2012-01-25 |
2014-11-04 |
Demerx, Inc. |
Synthetic voacangine
|
CN104203272A
(zh)
|
2012-01-26 |
2014-12-10 |
长角牛疫苗和诊断有限责任公司 |
复合抗原序列及疫苗
|
TW201348226A
(zh)
|
2012-02-28 |
2013-12-01 |
Amgen Inc |
作為pim抑制劑之醯胺
|
TW201348231A
(zh)
|
2012-02-29 |
2013-12-01 |
Amgen Inc |
雜雙環化合物
|
CN107375898A
(zh)
|
2012-03-19 |
2017-11-24 |
奇达拉治疗公司 |
用于棘白菌素类化合物的给药方案
|
AU2013235491A1
(en)
|
2012-03-22 |
2014-09-11 |
Nanotherapeutics, Inc. |
Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles
|
KR101956586B1
(ko)
*
|
2012-03-27 |
2019-03-11 |
일양약품주식회사 |
약제학적 조성물 및 이의 제조방법
|
WO2013148978A1
(en)
|
2012-03-30 |
2013-10-03 |
Lexicon Pharmaceuticals, Inc. |
Methods and compositions for the treatment of necrotizing enterocolitis
|
WO2013155422A1
(en)
|
2012-04-12 |
2013-10-17 |
Ironwood Pharmaceuticals, Inc. |
Methods of treating alopecia and acne
|
US9452107B2
(en)
|
2012-04-16 |
2016-09-27 |
New Jersey Institute Of Technology |
Systems and methods for superdisintegrant-based composite particles for dispersion and dissolution of agents
|
WO2013166296A1
(en)
|
2012-05-02 |
2013-11-07 |
Exelixis, Inc. |
A dual met - vegf modulator for treating osteolytic bone metastases
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US10688041B2
(en)
|
2012-05-03 |
2020-06-23 |
Kala Pharmaceuticals, Inc. |
Compositions and methods utilizing poly(vinyl alcohol) and/or other polymers that aid particle transport in mucus
|
JP6360039B2
(ja)
|
2012-05-03 |
2018-07-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
|
AU2013259150B2
(en)
|
2012-05-11 |
2016-07-14 |
Activus Pharma Co., Ltd. |
Organic compound nanopowder, production method therefor, and suspension
|
JP6234443B2
(ja)
|
2012-05-17 |
2017-11-22 |
ブイティーブイ・セラピューティクス・エルエルシー |
糖尿病治療のためのグルコキナーゼ活性化因子組成物
|
KR20200017549A
(ko)
|
2012-06-04 |
2020-02-18 |
파마싸이클릭스 엘엘씨 |
브루톤 타이로신 키나아제 저해제의 결정 형태
|
AR091436A1
(es)
|
2012-06-14 |
2015-02-04 |
Amgen Inc |
Compuestos de azetidina y piperidina utiles como inhibidores de pde10
|
CA2914782C
(en)
|
2012-06-21 |
2021-05-25 |
Phosphorex, Inc. |
Nanoparticles of indirubin, derivatives thereof and methods of making and using same
|
WO2014006100A1
(en)
|
2012-07-05 |
2014-01-09 |
Ucb Pharma S.A. |
Treatment for bone diseases
|
GB201212010D0
(en)
|
2012-07-05 |
2012-08-22 |
Sigmoid Pharma Ltd |
Formulations
|
EP2872205B1
(en)
|
2012-07-12 |
2017-02-08 |
MannKind Corporation |
Dry powder drug delivery systems
|
US9163023B2
(en)
|
2012-07-12 |
2015-10-20 |
Viiv Healthcare Uk Limited |
Compounds and methods for treating HIV
|
JOP20130213B1
(ar)
|
2012-07-17 |
2021-08-17 |
Takeda Pharmaceuticals Co |
معارضات لمستقبلht3-5
|
WO2014022752A1
(en)
|
2012-08-03 |
2014-02-06 |
Amgen Inc. |
Macrocycles as pim inhibitors
|
JP6193374B2
(ja)
|
2012-08-13 |
2017-09-06 |
武田薬品工業株式会社 |
Gpr6モジュレーターとしてのキノキサリン誘導体
|
EP2887934A1
(en)
|
2012-08-22 |
2015-07-01 |
XenoPort, Inc. |
Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
|
US20140348915A9
(en)
|
2012-08-22 |
2014-11-27 |
Xenoport, Inc. |
Oral Dosage Forms of Methyl Hydrogen Fumarate and Prodrugs Thereof
|
US9605276B2
(en)
|
2012-08-24 |
2017-03-28 |
Etubics Corporation |
Replication defective adenovirus vector in vaccination
|
WO2014036016A1
(en)
|
2012-08-31 |
2014-03-06 |
Principia Biopharma Inc. |
Benzimidazole derivatives as itk inhibitors
|
WO2014036528A2
(en)
|
2012-08-31 |
2014-03-06 |
Ixchel Pharma, Llc |
Agents useful for treating obesity, diabetes and related disorders
|
PL2892900T3
(pl)
|
2012-09-10 |
2018-02-28 |
Principia Biopharma Inc. |
Związki pyrazolopirymidonowe jako inhibitory kinazy
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
CN104853754A
(zh)
|
2012-11-20 |
2015-08-19 |
普林斯匹亚生物制药公司 |
作为jak3抑制剂的氮杂吲哚衍生物
|
UY35148A
(es)
|
2012-11-21 |
2014-05-30 |
Amgen Inc |
Immunoglobulinas heterodiméricas
|
WO2014085489A1
(en)
|
2012-11-30 |
2014-06-05 |
Sanford-Burnham Medical Research Institute |
Inhibitor of apoptosis protein (iap) antagonists
|
WO2014091318A1
(en)
|
2012-12-11 |
2014-06-19 |
Lupin Atlantis Holdings, S.A. |
Reduced dose pharmaceutical compositions of fenofibrate
|
WO2014100021A1
(en)
|
2012-12-17 |
2014-06-26 |
Exelixis, Inc. |
Tgr5 agonists: imidazole and triazole compounds containing a quaternary nitrogen
|
US8940728B2
(en)
|
2012-12-20 |
2015-01-27 |
Demerx, Inc. |
Substituted noribogaine
|
US9045481B2
(en)
|
2012-12-20 |
2015-06-02 |
Demerx, Inc. |
Substituted noribogaine
|
JP2016508979A
(ja)
|
2012-12-20 |
2016-03-24 |
デメレックス, インコーポレイテッド |
置換ノルイボガイン
|
MX2015009901A
(es)
|
2013-02-01 |
2016-04-06 |
Santa Maria Biotherapeutics Inc |
Administración de un compuesto de antiactivina a a un sujeto.
|
BR112015020572B1
(pt)
*
|
2013-02-28 |
2022-02-22 |
Sun Chemical Corporation |
Processo contínuo para transformar sólido moído em dispersão líquida e aparelho
|
AU2014226290B2
(en)
*
|
2013-03-04 |
2018-11-15 |
Vtv Therapeutics Llc |
Stable glucokinase activator compositions
|
WO2014160177A2
(en)
|
2013-03-13 |
2014-10-02 |
Exelixis, Inc. |
Quinazoline inhibitors of pi3k
|
CN105188710A
(zh)
|
2013-03-15 |
2015-12-23 |
葛兰素史密丝克莱恩生物有限公司 |
包含缓冲的氨基烷基氨基葡糖苷磷酸酯衍生物的组合物及其用于增强免疫应答的用途
|
US9732068B1
(en)
|
2013-03-15 |
2017-08-15 |
GenSyn Technologies, Inc. |
System for crystalizing chemical compounds and methodologies for utilizing the same
|
ES2754388T3
(es)
|
2013-03-15 |
2020-04-17 |
Mannkind Corp |
Composiciones y métodos de dicetopiperazina microcristalina
|
US10179118B2
(en)
|
2013-03-24 |
2019-01-15 |
Arbor Pharmaceuticals, Llc |
Pharmaceutical compositions of dimethyl fumarate
|
US11813275B2
(en)
|
2013-04-05 |
2023-11-14 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
PT2981271T
(pt)
|
2013-04-05 |
2019-02-19 |
Boehringer Ingelheim Int |
Utilizações terapêuticas de empagliflozina
|
US20140303097A1
(en)
|
2013-04-05 |
2014-10-09 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition, methods for treating and uses thereof
|
EP4000608A1
(en)
|
2013-04-18 |
2022-05-25 |
Boehringer Ingelheim International GmbH |
Pharmaceutical composition, methods for treating and uses thereof
|
US9630963B2
(en)
|
2013-05-09 |
2017-04-25 |
Principia Biopharma, Inc. |
Quinolone derivatives as fibroblast growth factor inhibitors
|
WO2014197860A1
(en)
|
2013-06-07 |
2014-12-11 |
Xenoport, Inc. |
Method of making monomethyl fumarate
|
AP2015008919A0
(en)
|
2013-06-20 |
2015-12-31 |
Glenmark Pharmaceuticals Sa |
Nanoparticulate formulation comprising a trpa1 antagonist
|
US9421182B2
(en)
|
2013-06-21 |
2016-08-23 |
Xenoport, Inc. |
Cocrystals of dimethyl fumarate
|
MX2016000739A
(es)
|
2013-07-18 |
2017-04-06 |
Mannkind Corp |
Composiciones farmacéuticas en polvo seco estables al calor y métodos.
|
EP3030294B1
(en)
|
2013-08-05 |
2020-10-07 |
MannKind Corporation |
Insufflation apparatus
|
WO2015035184A1
(en)
|
2013-09-06 |
2015-03-12 |
Xenoport, Inc. |
Crystalline forms of (n,n-diethylcarbamoyl)methyl methyl (2e)but-2-ene-1,4-dioate, methods of synthesis and use
|
US20150079180A1
(en)
|
2013-09-18 |
2015-03-19 |
Xenoport, Inc. |
Nanoparticle compositions of dimethyl fumarate
|
GB201319791D0
(en)
|
2013-11-08 |
2013-12-25 |
Sigmoid Pharma Ltd |
Formulations
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
EP2878311A1
(en)
|
2013-11-27 |
2015-06-03 |
Freund Pharmatec Ltd. |
Solubility Enhancement for Hydrophobic Drugs
|
EP3091984B1
(en)
|
2014-01-09 |
2020-04-22 |
The J. David Gladstone Institutes, A Testamentary Trust Established under The Will of J. David Gladstone |
Substituted benzoxazine and related compounds
|
WO2015108945A2
(en)
|
2014-01-14 |
2015-07-23 |
Board Of Regents Of The University Of Nebraska |
Compositions and methods for the delivery of therapeutics
|
WO2015108783A1
(en)
|
2014-01-16 |
2015-07-23 |
The Brigham And Women's Hospital, Inc. |
Targeted delivery of immunoregulatory drugs
|
JP6504548B2
(ja)
|
2014-02-21 |
2019-04-24 |
プリンシピア バイオファーマ インコーポレイテッド |
Btk阻害剤の塩および固体形態
|
EP3114124A1
(en)
|
2014-03-03 |
2017-01-11 |
Principia Biopharma, Inc. |
BENZIMIDAZOLE DERIVATIVES AS RLK and ITK INHIBITORS
|
US20150250776A1
(en)
|
2014-03-05 |
2015-09-10 |
Nanotherapeutics, Inc. |
Compositions and methods for oral delivery of encapsulated 3-aminopyridine-2-carboxaldehyde particles
|
US9999672B2
(en)
|
2014-03-24 |
2018-06-19 |
Xenoport, Inc. |
Pharmaceutical compositions of fumaric acid esters
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
PL3134084T3
(pl)
|
2014-04-25 |
2021-09-27 |
Exelixis, Inc. |
Sposób leczenia gruczolakoraka płuca
|
JP2017515840A
(ja)
|
2014-05-12 |
2017-06-15 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
感染症を治療するためのダニリキシンを含む医薬組成物
|
US9526734B2
(en)
|
2014-06-09 |
2016-12-27 |
Iceutica Pty Ltd. |
Formulation of meloxicam
|
CA2989550C
(en)
|
2014-06-18 |
2023-08-08 |
Demerx, Inc. |
Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them
|
US10654843B2
(en)
|
2014-06-20 |
2020-05-19 |
Principia Biopharma Inc. |
LMP7 inhibitors
|
CA2952567A1
(en)
|
2014-06-25 |
2015-12-30 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline salts of (s)-6-((1-acetylpiperidin-4-yl)amino)-n-(3-(3,4-dihydroisoquinolin-2(1h)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide
|
ES2723429T3
(es)
|
2014-08-01 |
2019-08-27 |
Glenmark Pharmaceuticals Sa |
Formulación de nanopartículas que comprende un inhibidor de mPGES-1
|
US10016415B2
(en)
|
2014-08-18 |
2018-07-10 |
Alkermes Pharma Ireland Limited |
Aripiprazole prodrug compositions
|
SI3182958T2
(sl)
*
|
2014-08-18 |
2022-07-29 |
Alkermes Pharma Ireland Limited |
Sestavki aripiprazol predzdravila
|
US20170246187A1
(en)
|
2014-08-28 |
2017-08-31 |
Lipocine Inc. |
(17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
|
WO2016033556A1
(en)
|
2014-08-28 |
2016-03-03 |
Lipocine Inc. |
BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
|
SG10201902499VA
(en)
|
2014-09-03 |
2019-04-29 |
Genesegues Inc |
Therapeutic nanoparticles and related compositions, methods and systems
|
CA2960451A1
(en)
|
2014-09-08 |
2016-03-17 |
Glaxosmithkline Intellectual Property Development Limited |
Crystalline forms of 2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-n-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide
|
PL3201203T3
(pl)
|
2014-09-29 |
2021-11-22 |
Takeda Pharmaceutical Company Limited |
Krystaliczna postać 1-(1-metylo-1h-pirazol-4-ilo)-n-((1r,5s,7s)-9-metylo-3-oksa-9-azabicyklo[3.3.1]nonan-7-ylo)-1h-indolo-3-karboksyamidu
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
EP3203995A4
(en)
|
2014-10-09 |
2019-05-15 |
Board of Regents of the University of Nebraska |
COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS
|
EP3881829A1
(en)
|
2014-11-07 |
2021-09-22 |
Sublimity Therapeutics Limited |
Compositions comprising cyclosporin
|
EP3223796B1
(en)
*
|
2014-11-25 |
2021-07-21 |
Curadigm Sas |
Pharmaceutical compositions, preparation and uses thereof
|
MA41142A
(fr)
|
2014-12-12 |
2017-10-17 |
Amgen Inc |
Anticorps anti-sclérostine et utilisation de ceux-ci pour traiter des affections osseuses en tant qu'élements du protocole de traitement
|
US10695417B2
(en)
|
2015-01-09 |
2020-06-30 |
Etubics Corporation |
Human adenovirus serotype 5 vectors containing E1 and E2B deletions encoding the ebola virus glycoprotein
|
CN104587457B
(zh)
*
|
2015-01-13 |
2017-03-22 |
广东海大畜牧兽医研究院有限公司 |
一种利用难溶或不溶蛋白、多肽抗原制备纳米微粒疫苗的方法
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
MX369634B
(es)
|
2015-02-20 |
2019-11-14 |
Cytec Ind Inc |
Composiciones de dialquil sulfosuccinato, metodos para hacerlas y metodos de uso.
|
BR112017018931A2
(pt)
|
2015-03-03 |
2018-07-31 |
Pharmacyclics Llc |
formulações farmacêuticas de um inibidor de tirosina quinase de bruton
|
WO2016154362A1
(en)
|
2015-03-23 |
2016-09-29 |
The Brigham And Women's Hospital, Inc. |
Tolerogenic nanoparticles for treating diabetes mellitus
|
CA3019769C
(en)
|
2015-04-21 |
2021-10-12 |
Sunovion Pharmaceuticals Inc. |
Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
|
WO2016183292A1
(en)
|
2015-05-14 |
2016-11-17 |
Longhorn Vaccines And Diagnostics, Llc |
Rapid methods for the extraction of nucleic acids from biological samples
|
EP3298011B1
(en)
|
2015-05-22 |
2021-11-17 |
Principia Biopharma Inc. |
Quinolone derivatives as fibroblast growth factor receptor inhibitors
|
EP4112618A1
(en)
|
2015-06-03 |
2023-01-04 |
Principia Biopharma Inc. |
Tyrosine kinase inhibitors
|
TW201718572A
(zh)
|
2015-06-24 |
2017-06-01 |
普林斯匹亞生物製藥公司 |
酪胺酸激酶抑制劑
|
EP3317287B1
(en)
|
2015-07-02 |
2019-07-31 |
GlaxoSmithKline Intellectual Property Development Limited |
Inhibitors of indoleamine 2,3-dioxygenase
|
WO2017004609A1
(en)
|
2015-07-02 |
2017-01-05 |
Exelixis, Inc. |
Thiadiazole modulators of s1p and methods of making and using
|
WO2017004608A1
(en)
|
2015-07-02 |
2017-01-05 |
Exelixis, Inc. |
Oxadiazole modulators of s1p methods of making and using
|
WO2017004610A1
(en)
|
2015-07-02 |
2017-01-05 |
Exelixis, Inc. |
Tercyclic s1p3-sparing, s1p1 receptor agonists
|
CN108026140A
(zh)
|
2015-07-28 |
2018-05-11 |
葛兰素史克知识产权第二有限公司 |
用于预防或治疗hiv感染的白桦脂醇衍生物
|
CA2993758A1
(en)
|
2015-07-28 |
2017-02-02 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Betuin derivatives for preventing or treating hiv infections
|
RU2018112749A
(ru)
|
2015-09-24 |
2019-10-24 |
ГлаксоСмитКлайн Интеллекчуал Проперти (N 2) Лимитед |
Модуляторы индоламин-2,3-диоксигеназы
|
WO2017051354A1
(en)
|
2015-09-24 |
2017-03-30 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Modulators of indoleamine 2,3-dioxygenase
|
CN108368071A
(zh)
|
2015-09-24 |
2018-08-03 |
葛兰素史克知识产权第二有限公司 |
具有hiv成熟抑制活性的化合物
|
CN108135838A
(zh)
|
2015-10-16 |
2018-06-08 |
马瑞纳斯制药公司 |
包含纳米粒的可注射神经类固醇制剂
|
WO2017130156A1
(en)
|
2016-01-27 |
2017-08-03 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Ingenol analogs, pharmaceutical compositions and methods of use thereof
|
WO2017142947A1
(en)
|
2016-02-17 |
2017-08-24 |
Global Blood Therapeutics, Inc. |
Histone methyltransferase inhibitors
|
ES2893973T3
(es)
|
2016-02-17 |
2022-02-10 |
Alkermes Pharma Ireland Ltd |
Composiciones de múltiples profármacos de aripiprazol
|
US10590084B2
(en)
|
2016-03-09 |
2020-03-17 |
Blade Therapeutics, Inc. |
Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof
|
GB201604124D0
(en)
|
2016-03-10 |
2016-04-27 |
Ucb Biopharma Sprl |
Pharmaceutical formulation
|
UA124768C2
(uk)
|
2016-06-30 |
2021-11-17 |
Дьюрект Корпорейшн |
Депо-препарат
|
US10682340B2
(en)
|
2016-06-30 |
2020-06-16 |
Durect Corporation |
Depot formulations
|
TW201811376A
(zh)
|
2016-07-01 |
2018-04-01 |
英商葛蘭素史密斯克藍智慧財產權有限公司 |
抗體-藥物結合物及使用其之治療方法
|
EP3481835A4
(en)
|
2016-07-05 |
2020-02-26 |
Blade Therapeutics, Inc. |
CALPAIN MODULATORS AND THEIR THERAPEUTIC USES
|
AU2017311412B2
(en)
|
2016-08-11 |
2023-05-18 |
Ovid Therapeutics Inc. |
Methods and compositions for treatment of epileptic disorders
|
IL297367A
(en)
|
2016-08-19 |
2022-12-01 |
Orasis Pharmaceuticals Ltd |
Ophthalmic pharmaceutical preparations and uses related to them
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
CA3041033A1
(en)
|
2016-09-12 |
2018-03-15 |
Numerate, Inc. |
Monocyclic compounds useful as gpr120 modulators
|
EA038692B1
(ru)
|
2016-09-13 |
2021-10-05 |
Киова Кирин Ко., Лтд. |
Фармацевтическая композиция
|
SG10201912574WA
(en)
|
2016-09-28 |
2020-02-27 |
Blade Therapeutics Inc |
Calpain modulators and therapeutic uses thereof
|
CN109803636B
(zh)
*
|
2016-10-11 |
2022-06-17 |
帝斯曼知识产权资产管理有限公司 |
纳米级紫外线吸收剂的制备
|
EP3544614A4
(en)
|
2016-11-28 |
2020-08-05 |
Lipocine Inc. |
ORAL TESTOSTERONE UNDECANOATE THERAPY
|
BR112019012285B1
(pt)
|
2016-12-16 |
2023-04-04 |
Koppers Performance Chemicals Inc. |
Método para tratar madeira ou produto de madeira e madeira ou produto de madeira
|
EP3558971B1
(en)
|
2016-12-22 |
2022-02-23 |
Global Blood Therapeutics, Inc. |
Histone methyltransferase inhibitors
|
ES2874638T3
(es)
|
2017-01-18 |
2021-11-05 |
Principia Biopharma Inc |
Inhibidores inmunoproteosómicos
|
KR102645511B1
(ko)
|
2017-04-10 |
2024-03-08 |
시에라 온코로지 엘엘씨 |
종양 성장을 저해하는 CHK1(SRA737)/PARPi 조합 방법
|
CN110753683B
(zh)
|
2017-04-11 |
2024-02-09 |
吉斯诺治疗公司 |
咔唑化合物及其使用方法
|
RU2018138121A
(ru)
|
2017-04-21 |
2021-05-21 |
Байо-Сайнектикс Инк. |
Способ приготовления наночастицы активного ингредиента с использованием липида в качестве смазывающего вещества в процессе помола
|
CN110997671A
(zh)
|
2017-06-09 |
2020-04-10 |
全球血液疗法股份有限公司 |
作为组蛋白甲基转移酶抑制剂的氮杂吲哚化合物
|
CN115252548A
(zh)
|
2017-07-14 |
2022-11-01 |
詹森药业有限公司 |
长效配制品
|
WO2019036384A1
(en)
|
2017-08-15 |
2019-02-21 |
Global Blood Therapeutics, Inc. |
TRICYCLIC COMPOUNDS AS HISTONE INHIBITORS METHYLTRANSFERASES
|
SG11202001090WA
(en)
|
2017-08-15 |
2020-03-30 |
Global Blood Therapeutics Inc |
Tricyclic compounds as histone methyl-transferase inhibitors
|
WO2019087016A1
(en)
|
2017-10-30 |
2019-05-09 |
Glaxosmithkline Intellectual Property Development Limited |
Compounds useful in hiv therapy
|
ES2928787T3
(es)
|
2017-11-16 |
2022-11-22 |
Principia Biopharma Inc |
Inhibidores del inmunoproteasoma
|
WO2019099582A1
(en)
|
2017-11-16 |
2019-05-23 |
Principia Biopharma Inc. |
Immunoproteasome inhibitors
|
WO2019140365A1
(en)
|
2018-01-12 |
2019-07-18 |
Board Of Regents Of The University Of Nebraska |
Antiviral prodrugs and formulations thereof
|
DE102018103528A1
(de)
|
2018-02-16 |
2019-08-22 |
Friedrich-Alexander-Universität Erlangen-Nürnberg |
Suspension nanoskaliger, organischer Partikel und Verfahren zu ihrer Herstellung
|
WO2019169029A1
(en)
|
2018-02-28 |
2019-09-06 |
Bioxiness Pharmaceuticals, Inc. |
Target specific chemotherapeutic agents
|
WO2019169017A1
(en)
|
2018-02-28 |
2019-09-06 |
Bioxiness Pharmaceuticals, Inc. |
Chemotherapeutic agents
|
WO2019171174A2
(en)
*
|
2018-03-07 |
2019-09-12 |
St Ip Holding Ag |
Combination compositions and therapies comprising 4-methyl-5-(pyrazin-2-yl)-3h-1,2-dithiole-3-thione, and methods of making and using same
|
US20200407393A1
(en)
|
2018-03-07 |
2020-12-31 |
Glaxosmithkline Intellectual Property (No. 2) Limited |
Medical Use
|
WO2019191534A1
(en)
|
2018-03-30 |
2019-10-03 |
Amgen Inc. |
C-terminal antibody variants
|
CA3132832A1
(en)
|
2018-04-09 |
2019-10-17 |
Howard E. Gendelman |
Antiviral prodrugs and formulations thereof
|
EA202092952A1
(ru)
|
2018-06-11 |
2021-03-22 |
Оцука Фармасьютикал Ко., Лтд. |
Содержащая деламанид композиция
|
AU2019287437A1
(en)
|
2018-06-12 |
2020-09-10 |
Vtv Therapeutics Llc |
Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
|
MX2021001612A
(es)
|
2018-08-09 |
2021-05-13 |
Glaxosmithkline Ip No 2 Ltd |
Compuestos utiles en terapia del vih.
|
EP3844164A1
(en)
|
2018-08-30 |
2021-07-07 |
GlaxoSmithKline Intellectual Property (No.2) Limited |
Compounds useful in hiv therapy
|
WO2020121006A2
(en)
|
2018-10-19 |
2020-06-18 |
Innostudio Inc. |
Method and apparatus to produce nanoparticles in an ostwald ripening flow device with tubes of variable path length
|
JP7406556B2
(ja)
|
2018-11-30 |
2023-12-27 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッド |
Hiv療法に有用な化合物
|
WO2020118142A1
(en)
|
2018-12-07 |
2020-06-11 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of pospartum depression
|
CN113614074A
(zh)
|
2019-01-22 |
2021-11-05 |
罗斯坎普研究所 |
用于治疗炎性疾病的氨基酸衍生物
|
AU2020221821A1
(en)
|
2019-02-13 |
2021-08-26 |
The Brigham And Women's Hospital, Inc. |
Anti-peripheral lymph node addressin antibodies and uses thereof
|
EP3934760A1
(en)
|
2019-03-06 |
2022-01-12 |
GlaxoSmithKline Intellectual Property (No.2) Limited |
Compounds useful in hiv therapy
|
EP4249070A3
(en)
|
2019-04-12 |
2024-04-17 |
Riboscience LLC |
Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors
|
JP2022543837A
(ja)
|
2019-08-05 |
2022-10-14 |
マリナス ファーマシューティカルズ, インコーポレイテッド |
てんかん重積状態の治療に使用するためのガナキソロン
|
US20220259252A1
(en)
|
2019-08-08 |
2022-08-18 |
Glaxosmithkline Intellectual Property (No.2) Limited |
4'-ethynyl-2'-deoxyadenosine derivatives and their use in hiv therapy
|
US20220298160A1
(en)
|
2019-08-28 |
2022-09-22 |
Glaxosmithkline Intellectual Property (No.2) Limited |
Compounds useful in hiv therapy
|
US20230339880A1
(en)
|
2019-10-11 |
2023-10-26 |
Corbus Pharmaceuticals, Inc. |
Compositions of ajulemic acid and uses thereof
|
IL293525A
(en)
|
2019-12-06 |
2022-08-01 |
Marinus Pharmaceuticals Inc |
Ganaxolone for use in the treatment of multiple sclerosis complex
|
WO2021150476A1
(en)
|
2020-01-20 |
2021-07-29 |
Genzyme Corporation |
Therapeutic tyrosine kinase inhibitors for relapsing multiple sclerosis (rms)
|
KR20220158031A
(ko)
|
2020-03-26 |
2022-11-29 |
피엘엑스 옵코 인코포레이티드 |
pH 의존성 재구성이 가능한 제약 담체 및 그의 제조 및 사용 방법
|
KR20230004618A
(ko)
|
2020-04-17 |
2023-01-06 |
젠자임 코포레이션 |
전신성 과염증 반응을 수반하는 병태 치료에 사용하기 위한 에클리타세르팁
|
CN115443136A
(zh)
|
2020-04-22 |
2022-12-06 |
普林斯匹亚生物制药公司 |
使用btk抑制剂对急性呼吸窘迫综合征和涉及细胞因子风暴的其他障碍的治疗
|
EP3928772B1
(en)
|
2020-06-26 |
2024-06-19 |
Algiax Pharmaceuticals GmbH |
Nanoparticulate composition
|
CN115776882A
(zh)
|
2020-07-09 |
2023-03-10 |
詹森药业有限公司 |
长效配制品
|
EP4178540A1
(en)
|
2020-07-09 |
2023-05-17 |
JANSSEN Pharmaceutica NV |
Long-acting formulations
|
CN115867259A
(zh)
|
2020-07-09 |
2023-03-28 |
詹森药业有限公司 |
长效配制品
|
US11980636B2
(en)
|
2020-11-18 |
2024-05-14 |
Jazz Pharmaceuticals Ireland Limited |
Treatment of hematological disorders
|
CN112451520B
(zh)
*
|
2020-12-31 |
2021-10-15 |
江苏宇锐医药科技有限公司 |
一种缬沙坦氨氯地平组合物及其制备方法
|
JP2024507550A
(ja)
|
2021-02-23 |
2024-02-20 |
ヴィーブ、ヘルスケア、カンパニー |
Hiv療法に有用な化合物
|
WO2023023473A1
(en)
|
2021-08-16 |
2023-02-23 |
Sierra Oncology, Inc. |
Methods of using momelotinib to treat chronic kidney disease
|
WO2023034743A1
(en)
*
|
2021-08-31 |
2023-03-09 |
Natsar Pharmaceuticals, Inc. |
Intravenous formulations of rk-33
|
WO2023239727A1
(en)
|
2022-06-06 |
2023-12-14 |
The Usa, As Represented By The Secretary, Dept. Of Health And Human Services |
Lats inhibitors and uses thereof
|
WO2023244672A1
(en)
|
2022-06-14 |
2023-12-21 |
Assembly Biosciences, Inc. |
2-(imidazo[1, 2-a]1,8-naphthyridin-8-yl)-1,3,4-oxadiazole derivatives as enhancers of innate immune response for the treatment of viral infections
|
WO2024006406A1
(en)
|
2022-06-30 |
2024-01-04 |
Genzyme Corporation |
Therapeutic tyrosine kinase inhibitors for multiple sclerosis and myasthenia gravis
|
TW202408487A
(zh)
|
2022-07-06 |
2024-03-01 |
美商維維迪昂醫療公司 |
包含wrn解旋酶抑制劑之醫藥組成物
|
TW202409001A
(zh)
|
2022-07-06 |
2024-03-01 |
美商維維迪昂醫療公司 |
包含wrn解旋酶抑制劑之醫藥組成物
|
WO2024068699A1
(en)
|
2022-09-28 |
2024-04-04 |
Janssen Pharmaceutica Nv |
Long-acting formulations
|
WO2024068693A1
(en)
|
2022-09-28 |
2024-04-04 |
Janssen Pharmaceutica Nv |
Long-acting formulations
|
US20240173313A1
(en)
|
2022-10-11 |
2024-05-30 |
Genzyme Corporation |
Therapeutic tyrosine kinase inhibitors for multiple sclerosis
|
CN115844821B
(zh)
*
|
2023-01-03 |
2024-05-17 |
江苏知原药业股份有限公司 |
一种地奈德纳米晶混悬液、制备方法及其应用
|